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Abstract  
Amyloids are protein aggregates that build up as plaques in various tissues in the body 
and are associated with a number of diseases. Of the amyloidoses, Alzheimer’s disease (AD) is 
the most known and socially distressing. Amyloid-beta (Abeta) is the amyloidogenic protein 
associated with AD and is implicated in the etiology of the disease. Abeta aggregation is highly 
heterogeneuos, giving rise to a number of possible aggregation pathways and intermediate 
oligomeric structures. The mechanism of Abeta aggregation was studied here in the presence and 
absence of a model cell membranes employing fluorescence spectrosopy, light scattering, atomic 
force microscopy, and NMR spectroscopy.  
First, Abeta aggregation is investigated in the presence of a lipid bilayer, exploring the 
particular role of lipid composition on the mechanism of membrane disruption. It was shown that 
membrane disruption by Abeta occurs by a two-step process: (i) intial formation of ion-selective 
pores followed by (ii) non-specific fragmentation of the lipid membrane during amyloid fiber 
formation. Moreover, the presence of gangliosides enhances pore formation and is necessary for 
fiber-dependent membrane fragmentation. 
Next, magic angle spinning (MAS) NMR is used to gain structural insights on an Abeta 
oligomer, providing atomic-level characterization on a non-fibrillar product of Abeta. 
Importantly, it is demonstrated that MAS NMR and 1H-1H dipolar interactions can be used as a 
spectral filter to detect Abeta oligomers without a purification procedure. In comparison to other 
solid-state NMR techniques, the experiment is extraordinarily selective and sensitive, as it can 
resolve spectra on a small population of oligomers (7% of the total Abeta concentration). Using 
 xi 
this method, it was shown that a stable, primarily disordered Abeta oligomer forms and coexists 
with amyloid fibers. 
Finally, a real-time 2D NMR method is implemented to study the mechanism of Abeta 
fiber elongation. It is demonstrated that monomeric Abeta undergoes a conformational 
conversion after binding to the fiber surface to complete the elongation step, with the strongest 
interaction occurring in the central region of the peptide (residues Phe19- Glu22). To our 
knowledge, this is the first high-resolution account of the fiber elongation process and provides 
residue-specific details of amyloid fiber polymorphism. 
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Chapter 1: Introduction 
Portions of this chapter have been adapted from the following publication:  
Kotler, S.A., Walsh, P., Brender, J.R., and Ramamoorthy, A. (2014) Differences between 
amyloid-β aggregation in solution and on the membrane: elucidating mechanistic insights 
into Alzheimer’s disease. Chemical Society Reviews. 43, 6692-6700. 
 
1.1  Introduction 
Amyloid deposits characterize more than twenty different clinical syndromes, each of 
which is associated with a distinct amyloid-forming protein. Neurodegenerative diseases such as 
Alzheimer’s, Parkinson’s, and Huntington’s diseases, in addition to localized diseases such as 
Type II Diabetes, are associated with the aggregation and misfolding of amyloidogenic 
peptides/proteins. Of these amyloid-related diseases, Alzheimer’s disease (AD) is the most 
known, affecting 5.2 million people in the United States and more than 24 million people 
worldwide (1). AD is clinically characterized by the presence of intracellular neurofibrillary 
tangles and extracellular senile plaques (2). The plaques consist of insoluble amyloid deposits 
composed primarily of aggregates of amyloid-β (Aβ) in their fibril form. The Aβ peptide is 
produced through proteolytic cleavage of the amyloid precursor protein (APP) by the β- and γ-
secretases (3). The predominant Aβ species formed are the Aβ40 and Aβ42 peptides (consisting 
of 40 and 42 residues, respectively); with the Aβ42 variant being an indicator of a progressive 
AD state (Fig. 1.1) (4). The accumulation of Aβ40 and Aβ42 into long, unbranched fibrils is a 
hallmark of the disease, as is the loss of neurons due to cell death in parallel with the Aβ 
aggregation process (2, 5). Amyloid fibrils of Aβ40 and Aβ42 form a parallel, in-register cross β-
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sheet structure that binds to fibril-specific dyes such as congo red and thioflavin-T (ThT) (6). 
Prior to fibril formation, Aβ forms a myriad of structures in the monomeric and oligomeric 
states, all of which result in similar fibril structures (3). Neurotoxicity by Aβ is convoluted as it 
is unknown which misfolded species causes cell death, in addition to the mechanism by which a 
particular misfolded state causes toxicity. This data has been correlated with brain samples from 
patients with and without AD, and, to this day, the Aβ fibrils define and confirm the diagnosis of 
AD patients’ post-mortem (4). 
 
 
Figure 1.1 Aβ peptides derive from the proteolytic cleavage of the amyloid precursor protein (APP). 
The β- and γ-secretases cleave APP to form the full length, amyloidogenic peptide Aβ peptide that ranges 
in length from 38-43 residues. When APP is processed by α-secretase, the non-amyloidogenic fragment 
Aβ(17-42) is formed (also known as the p3 fragment).  
Early AD research pointed to Aβ fibrils specifically as the neurotoxic agent leading to 
cellular death, memory loss, and other AD characteristics (7). Over the last two decades, further 
investigation has suggested that the fully-matured fibrils are no longer considered to be the main 
toxic agent; rather, oligomeric, prefibrillar species of the Aβ peptide have been shown to be most 
damaging to neuronal cells (3, 5, 8–10). There are several hypotheses regarding the mode of Aβ 
toxicity and they include the generation of reactive oxygen species, interaction with cell 
receptors, interactions with metals and direct disruption of cellular membranes (Fig. 1.2) (5). 
One widely accepted theory, called the amyloid hypothesis, deals with the notion that misfolded 
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intermediate states are responsible for cell death (3). Therefore, it is important to establish the 
relationship between misfolded entities, their structural properties, and how they confer toxicity. 
 
Figure 1.2 The amyloid hypothesis for Alzheimer’s disease.  
The aggregation of amyloid-β is highly diverse and poorly understood. Mounting evidence points to 
oligomers as being the most toxic agent in Alzheimer’s disease; however, intermediate structures are 
transient and heterogeneous. Additionally, the mechanism by which Aβ can be neurotoxic has not been 
fully elucidated. One prevailing hypothesis suggests that Aβ can be toxic through a membrane disruption 
mechanism.  
1.2  Structurally dissimilar Aβ oligomers give rise to varied neuronal toxicity 
While the toxicity of Aβ is under constant debate, the amyloid hypothesis has been 
supported by bodies of work suggesting that amyloid oligomers are the toxic amyloid species 
(11). The toxicity of soluble amyloid oligomers is not only relevant to AD, but to other amyloid 
diseases as well such as Parkinson’s disease and Type-II Diabetes where α-synuclein and human 
islet amyloid polypeptide (hIAPP) are indicated as the aggregative proteins, respectively (5, 12). 
In the case of Aβ, it is known that amyloid oligomers are toxic in vitro (13), with further 
evidence identifying oligomers as the culprit for in vivo toxicity (14). The problem herein arises 
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due to the fact that oligomers ranging in size and structural morphology have exhibited 
cytotoxicity (15).   
A wealth of structural data exists for the relatively benign fibrils of Aβ (6); however, 
intermediate structures such as structured monomers and oligomers have remained relatively 
unexplored, largely due to their transient nature. In this regard, the inability to crystallize and/or 
trap a pure (single state) sample has presented much of the difficulty in performing structural 
studies of oligomeric species. Relatively low-resolution methods, such as AFM, hydrogen-
deuterium exchange mass spectrometry, and circular dichroism (CD) have shown the wide size 
distribution of oligomers and variance in secondary structure. To further complicate matters, 
increasing the concentration to levels that are more amenable to atomic-resolution structural 
experiments can affect the aggregation time, decreasing the longevity of the oligomeric sample. 
Consequently, the sensitivity of aggregation results from a multitude of factors generating 
heterogeneous samples and hampering structural studies by techniques like nuclear magnetic 
resonance (NMR) and X-ray crystallography. 
The larger oligomers of Aβ have been mostly described as spherical, although studies 
have shown that circular, annular oligomers are producible in vitro (16, 17). One interesting 
aspect of Aβ oligomers and amyloid oligomers in general, is their ability to bind a common 
antibody regardless of structure. This ability to bind the A11 antibody indicates that amyloid 
oligomers across diseases and protein sequences share a common structure (16). This common β-
sheet-containing structure is fascinating, especially given structural evidence that Aβ40 forms a 
310 helix in solution (Fig. 2a), meaning a helix-to-β-sheet transition may occur (18). That being 
said, secondary structure-dependent toxicity has been the source of some debate. While most of 
the oligomers studied to date have contained β-sheet secondary structure, for relatively small 
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oligomers of Aβ42, it was determined that hydrophobic exposure and not the presence of β-
sheets are required for toxicity. The study also found that aggregate number is also not 
necessarily linked to toxicity; two similar sized globular oligomers were characterized and the 
more-hydrophobic exposed oligomer was toxic (19).  
 
Figure 1.3 Various structures of Aβ in solution and detergents characterized by NMR.  
(a) Aβ40 as a partially folded structure in the presence of 50 mM NaCl, with residues 13 to 23 forming a 
310 helix.18 (b) Solution NMR structure of 0.05% SDS-stabilized pre-globulomer of Aβ42 (top) 
compared with the basic fold of the fibrils of Aβ42 (bottom). Adapted with permission from Yu et al.21 
Copyright 2009 American Chemical Society. (c) Structural schematic of β-balls formed at low pH in the 
absence (top) and presence (bottom) of DSS. These structures both show a pinwheel, or micelle-like, 
arrangement of monomers. Reprinted with permission from Laurents et al. 2005. Copyright 2005 Journal 
of Biological Chemistry.20 
Some structural studies have utilized detergents or small molecules to stabilize both large 
(20) and small (21) oligomeric states with some success while others have utilized the freeze-
trapping of purified oligomers (9). Very large oligomers formed at low pH, described as amyloid 
“β-balls” and having a molecular weight of 764 kDa, have been studied at low-resolution. These 
very large assemblies can also be stabilized by DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid), 
and are hypothesized to have a pin-wheel-like structure, with monomers protruding radially 
outward (Fig. 2c) (20).  In the case of freeze-trapped large oligomers of Aβ40, structural studies 
by solid state NMR have identified fibril-like contacts (9). These large spherical oligomers 
contain primarily β-sheet secondary structure and are toxic to cultured neurons. Smaller Aβ42 
oligomers, thought to be pentamers, show a more loose arrangement with turns and C-termini 
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contained in the center of the oligomer (10). Polymerization of these “disk-shaped” oligomers 
into fibrils is thought to occur by association and lateral extension of parallel β-strands into 
fibrils. These pentamers are also toxic to cultured mouse neurons, even in the absence of β-sheet 
secondary structure. The collective theme associated with the three aforementioned structures is 
the idea of a pinwheel, or micelle-like, structure which may confirm the notion that oligomers of 
various size and sequence share a common structural element. 
Smaller oligomers, coined as pre-globulomers and globulomers, of Aβ42 described by 
Yu et al show similar molecular contacts to amyloid fibers of Aβ (Fig. 2b) (21). The pre-
globulomers (16 kDa) and globulomers (64 kDa) were stabilized by 0.05% sodium dodecyl 
sulphate (SDS) and studied by solution NMR. As with larger freeze trapped oligomers of Aβ40, 
the identification of these fibril-like structures provides a basis for the conversion of oligomers to 
fibrils, but do not directly explain the ability of Aβ to permeabilize cell membranes.  
Overall, high-resolution reports of fibril-like contacts for spherical oligomers of Aβ40 
have shown parallel β-sheets (9) while oligomers of Aβ42 demonstrated a lack of β-sheet 
secondary structure (10), highlighting the important difference observed between the structure 
and toxicity of these Aβ alloforms. Others have pointed to oligomers containing anti-parallel β-
sheets for the formation of pores and thus, the permeabilization of cell membranes (22). 
Annular oligomers, or annular protofibrils, are 8-20 nm in diameter and contain, as with 
spherical oligomers, a high β-sheet secondary structure (16). Despite the β-sheet content, circular 
oligomers are quite different from their spherical counterparts. It has been shown that these 
annular oligomers may share a common structure with β-barrel pores, such as α-hemolysin, 
through the binding of an anti-annular protofibril antibody to assembled α-hemolysin (16). 
Despite having a preformed pore-like structure, these circular oligomers do not permeabilize 
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membranes, but rather convert to spherical oligomers in the presence of lipids. Regardless of 
their inability to permeabilize membranes, annular protofibrils point to the possibility of a β-
barrel pore as the Aβ pore structure. 
The relationship between structure and cellular toxicity has been of primary focus in 
recent amyloid research. Given the number of reportedly different oligomeric Aβ species, 
relating these parameters could provide intuition into how we might go about preventing 
unfavorable folds from occurring. Despite the propensity of Aβ to form fibril-like intermediates 
early and late in its aggregation pathway, existing evidence suggests that the fold of toxic 
oligomers may differ considerably from that of the Aβ fibril (15, 23). As a result of the variance 
in secondary structure between different oligomer preparations, Aβ toxicity need not derive from 
a ‘single’ toxic species. In a recent study, Lashuel and co-workers argued that Aβ toxicity results 
from an “ongoing polymerization process” by demonstrating that a heterogeneous mixture of 
monomers and protofibrils were prone to heightened aggregation and, in turn, cytotoxicity (24). 
Neurotoxicity occurring by such a mechanism would only present greater difficulties in seeking 
therapeutic measures for alleviating AD symptoms, and attributes greater stress to understanding 
misfolding pathways as opposed to identifying individual toxic structures. 
While it is important to understand the structural link between intermediates and fibrils, 
their ultimate mode of action should be considered. Therefore, it is of utmost importance to gain 
structural and functional information on intermediates at their site of action, namely the 
membrane. Solid state NMR has proven to be an effective tool for the characterization of Aβ 
oligomer structures in the absence of the membrane. This technique has been a cornerstone of 
lipid biophysics as well, allowing researchers to effectively determine the integrity and dynamics 
of the lipid bilayer. With solid state NMR having been recently used to solve the structures and 
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dynamics of several membrane proteins (25) and membrane disrupting antimicrobial peptides 
(26), it stands to reason that this technique will be on the forefront of structural determination of 
Aβ in the membrane environment.  
1.3  The role of membrane composition and disruption in AD pathogenesis 
A number of studies have identified various possible mechanisms for cytotoxicity 
mediated by Aβ, and a prominent focus in AD pathology has centered on Aβ’s ability to disrupt 
membranes (5). In order to be cytotoxic via membrane disruption, Aβ aggregates must interact 
with the cellular surface by either a receptor or the lipid membrane. The mechanism of Aβ-
membrane interactions has not been fully elucidated; however, its interaction with the membrane 
is likely to affect the structure and properties of any type of aggregate. Dysregulation of ionic 
homeostasis, particularly of Ca2+, has been a consistent pathology in AD; thus, understanding 
the molecular mechanics by which Aβ induces ionic flux has become crucial to AD pathology 
(27). The cellular membrane in live cells is exceedingly complex, involving many variables that 
are difficult to isolate and control. Consequently, studying structural transitions of Aβ in the 
presence of membranes (with varying composition) and the ionic flux across a cellular 
membrane that results due to specific Aβ-membrane interactions has been extremely challenging. 
 
Figure 1.4 Model of GM1 ganglioside-clusters leading to the formation of toxic Aβ species.  
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Studies have found that low Aβ:GM1 ratios yield an α-helical Aβ structure, while an increasing Aβ:GM1 
ratio produces fibrils. Reprinted with permission from Ikeda et al. 2011. Copyright 2011 American 
Chemical Society (33). 
1.4  Ganglioside-containing membranes influence structural changes during Aβ 
aggregation 
Although obtaining structural models of Aβ oligomers is paramount to understanding the 
pathology of AD, the presence of membranes has been shown to strongly influence the Aβ 
aggregation pathway. While a number of studies have reported on the Aβ-membrane interaction, 
a great body of evidence points to gangliosides playing a significant role in altering the 
aggregation pathway of Aβ (28, 29). Gangliosides are glycospingolipids that contain a sialic acid 
headgroup moiety and play a substantial role in cell signaling and memory function. Early work 
identified Aβ fibrils tightly bound to monosialoganglioside (GM1), generating a 
conformationally distinct Aβ species (30). Since this work, a series of in vitro and in vivo studies 
demonstrated GM1 strongly influences the secondary structure of Aβ in the early and late stages 
of aggregation (31). Initial biophysical characterization demonstrated the pivotal role the sialic 
acid played in inducing such structural transitions (32). Work along this direction from the 
Matsuzaki group showed structural changes of Aβ upon interaction with GM1 was dependent 
upon the Aβ:GM1 ratio—for a low Aβ:GM1 ratio Aβ assumes an α-helix conformation, while at 
a high Aβ:GM1 ratio fibril formation ensues (Fig. 3) (29, 33). A great body of evidence from the 
Matsuzaki group has demonstrated Aβ amyloidogenicity can be altered in the presence of GM1-
containing membranes, with this effect being amplified by introducing Aβ to a lipid raft-like 
membrane mimetic. Cell viability assays showed that co-incubation of Aβ40 with GM1 in a lipid 
raft-like environment generated toxic amyloid species. Furthermore, concurrent measurements of 
the accumulation of Aβ and oligomer formation at the cell membrane were visualized with TIRF 
microscopy, revealing membrane-mediated aggregation affects fibril morphology (34). 
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The enhanced binding of Aβ to gangliosides is largely dependent upon the sialic acid of 
the headgroup moiety. Yet, McLaurin and Chakrabartty demonstrated that neither the ceramide 
nor the sialic acid alone could induce a partial helical structure; rather, the structural transition 
brought about by gangliosides is dependent upon the association of the sialic acid with the 
carbohydrate backbone (32). Recently, an NMR study came to a similar conclusion using the 
paramagnetic relaxation enhancement (PRE) effect to identify Aβ binding to GM1 at the sugar-
ceramide junction (35). In a related study, Williamson et al employed the use of chemical shift 
perturbations of uniformly 15N-labeled Aβ40 upon titration of GM1 and asialo-GM1 micelles as 
monitored by HSQC (heteronuclear single-quantum coherence) and revealed: i) the presence of 
the sialic acid in the ganglioside headgroup enhanced Aβ-GM1 binding, ii) Aβ binding to GM1 
was N-terminally driven, and iii) Aβ association is localized to His-13 and Leu-17 (36). In 
accordance with these data, a separate NMR study using 1H-15N TROSY and TROSY-based 
saturation transfer experiments, it was found that Aβ assumes a partial helical structure with an 
“up and down topological mode” when bound to GM1 micelles (35). A structure was not 
determined by this study from Utsumi et al; however, it was found through backbone chemical 
shifts that the regions of Aβ bound to GM1 micelles assumes discontinuous α-helices between 
residues His14-Val24 and Ile31-Val26 (other regions of the peptide being unstructured).  
The studies from Williamson et al and Utsumi et al seem to generate conflicting results of 
Aβ binding to gangliosides being N- or C-terminally driven. Yet, one can imagine a multi-step 
process involving initial electrostatic interactions with the N-terminus and hydrophobic 
interactions driving binding and/or insertion of the C-terminus into the GM1-containing 
membrane. The early biophysical characterization of the Aβ-GM1 interaction demonstrating the 
subtle dependence on the peptide:lipid ratio was corroborated by the more recent NMR studies. 
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Collectively, these data provide a better understanding for the production of structurally 
dissimilar Aβ aggregation states and heterogeneity in the aggregation pathway; the central 
dogma of the amyloid problem. It is well known that Aβ membrane binding is amplified by the 
presence of negatively charged lipid headgroups. Nonetheless, answering questions as to what 
makes for favorable binding to gangliosides and how gangliosides generate toxic amyloid 
species remain inadequate in the broader scope of AD pathology. While there is still much to be 
learned about the Aβ-ganglioside interaction, recent progress has been made in understanding 
how gangliosides might play a role in the mechanism of Aβ toxicity.  
1.5  Gangliosides mediate a two-step mechanism of amyloid-β membrane disruption 
Studying the interactions between Aβ and cellular membranes has proven to be of great 
importance, yet more insight must be gained by understanding the mechanism by which these 
oligomers can be toxic to cells. Aβ generates a multifactorial response in neurons, making the 
study of Aβ’s cytotoxicity difficult to pinpoint. While the exact mechanism of Aβ neuronal 
toxicity remains elusive, one of the long-standing pathologies is believed to arise from increased 
levels of cytosolic Ca2+ resulting from plasma membrane disruption (37). A number of in vitro 
studies over the last two decades demonstrated that ionic dyshomestasis can be caused by Aβ’s 
ability to form ion channel-like pores: an annular oligomer structure that allows ions to permeate 
the membrane through a pore of a hydrophilic interior and hydrophobic exterior (27). The 
resulting unregulated influx of Ca2+ is a result of the general properties of Aβ pores being cation 
selective and capable of being blockaded by Zn2+, suggesting these pores adopt a specific 
structure (37–39). Yet, there is little information on the structure adopted by Aβ upon its 
insertion to the membrane. Studies have suggested that pore structures contain a β-sheet rich 
conformation which is consistent with the current available structural data of Aβ; particularly the 
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common U-shaped motif found in amyloid structures (40). The concept of an explicit pore 
structure is further supported from a study by Capone et al, which demonstrated Aβ ion channels 
could be modulated by non-natural amino acid substitutions and emphasized the necessity of 
secondary structure for such channels to form (41). In a related study from Lal and colleagues, 
Aβ with an all D-amino acid sequence retains strikingly similar features known for the all L-
amino acids Aβ, demonstrating that chirality had no bearing on Aβ channel-like activity (42). 
The results using the all D-amino acids Aβ peptide are quite intriguing; however, in vivo toxicity 
measurements would provide a more definitive answer as to whether stereospecific, non-
stereospecific, or both mechanisms are involved in membrane perturbations. Nevertheless, both 
neurons and mitochondria are highly sensitive to perturbations in ionic strength, and a small 
perturbation in intracellular calcium levels caused by unregulated Aβ channel activity can trigger 
an apoptotic cascade.  
 
Figure 1.5 A two-step mechanism of membrane disruption by Aβ40.  
Upon addition of Aβ to a membrane solution (a), it is capable of binding to the membrane and forming 
ion channel-like pores (b). Appearance of Aβ pores is increased by the presence of gangliosides in the 
membrane composition. Furthermore, gangliosides mediate a second step of membrane disruption, a 
fiber-dependent step, which acts via a detergent-like mechanism to fragment the lipid bilayer (c). 
The amyloid channel hypothesis provides much insight into the membrane disruption 
mechanism by Aβ and other amyloid peptides; however, the mechanism by which Aβ stimulates 
ionic dyshomeostasis has not been fully elucidated. A multivariate analysis of Aβ cytotoxicity 
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found a negative correlation with both the particular cross-β sheet structure of amyloid fibers as 
well as the overall β-sheet content, contrary to the predicted models of Aβ pore structures (43). 
Moreover, spherical aggregates of Aβ have repeatedly shown to exhibit cytotoxicity (44, 45), and 
it is difficult to fathom how such structural polymorphs could form an Aβ ion channel.  
Recently, Sciacca et al demonstrated that membrane disruption by Aβ involves a two-step 
mechanism: (i) Aβ oligomers bind to the membrane to form ion permeable pores and (ii) the 
process of Aβ fibrillization causes membrane fragmentation via a detergent-like mechanism (Fig. 
4) (46). The first phase of this proposed two-step mechanism (Fig. 4b) shares many of the 
qualities observed for the previously described Aβ channel structures; namely, cation selectively 
and the ability to be blocked by Zn2+. The second step was found to be correlated with the 
formation of Aβ fibrils as revealed by leakage of the dye 6-carboxyfluorescein from large 
unilamellar vesicles (LUVs) and time course ThT measurements. Further examination of the 
fiber-dependent form of membrane disruption by 31P NMR and a lipid sedimentation assay led to 
the conclusion that this mechanism acted in a detergent-like manner. Unlike the Aβ pores, the 
second phase of membrane disruption displayed neither charge nor size selectively, lending 
support to the loss of the integrity of the membrane (Fig. 4c). Interestingly, completion of fibril 
polymerization halted progression of further membrane fragmentation, and, perhaps more 
intriguing, this phase of membrane disruption was entirely dependent upon gangliosides being 
part of the membrane composition. Given the overwhelming evidence for the effect of 
ganglioside-containing membranes on Aβ aggregation, the finding of a relationship between 
aggregation and membrane disruption is a step forward in bridging ideals for further elucidation 
of a mechanism. In a similar train of thought, fiber-dependent membrane disruption can be 
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correlated with the results previously discussed from Lashuel that ongoing polymerization was a 
key factor in cytotoxicity.  
It should be noted that both the pore and fiber-dependent mechanisms are not strictly 
characteristic of Aβ. For example, IAPP displays a similar biphasic effect in membrane 
disruption, and our group demonstrated that the fiber-dependent membrane permeabilization 
could be prevented by insulin (47) and both mechanisms could be modulated by the presence of 
PE lipids in the membrane composition (48). Furthermore, α-synuclein has been implicated as a 
membrane disrupting protein by pore formation and membrane fragmentation, in addition to 
other amyloidogenic proteins (38, 49). While there is an abundance of existing biophysical and 
biochemical data to support the amyloid hypothesis for Aβ and other amyloids, much more 
characterization needs to be done; namely, in the area of the therapeutic prevention of membrane 
disruption and further elucidation in the structure of misfolded intermediate states.  
1.6  Preventing membrane disruption by Aβ 
Small molecule compounds blocking Aβ channel formation and other forms of 
membrane disruption have the potential to alleviate Aβ-induced cytotoxicity. Current amyloid 
inhibitors target Aβ oligomers and fibrils outside the membrane (50, 51). For Aβ structures 
formed on and in the membrane this can be problematic as the small molecule EGCG has been 
shown to be less effective at the membrane surface (52). Given Aβ’s reactivity with the 
membrane, it is greatly important that small inhibitors such as EGCG have equal or superior 
efficacy at the peptide-membrane interface. Inhibitors of channel formation would therefore 
seem to be a very attractive target for stopping Aβ cytotoxicity. Such small molecules designed 
by Arispe and co-workers protected against the neurotoxic effect of Aβ and blocked ion 
conductance activity in model membranes (53). Unfortunately, the number of known channel 
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inhibitors of Aβ is currently very limited. Since the Aβ channel is formed by the oligomerization 
of Aβ, aggregation inhibitors are likely to influence Aβ channel formation. However, many 
aggregation inhibitors are specific to the fibrillar form of Aβ and therefore may not have activity 
against the specific oligomerization process that creates Aβ channels. Thus, an attractive 
approach would be to seek a set(s) of molecules to synergistically prevent all possible modes of 
membrane disruption by screening known inhibitors of Aβ aggregation as inhibitors of Aβ 
membrane disruption. If pore and oligomer formation are at least partially independent, as our 
previous data indicates, the elimination of either process alone will be insufficient to stop Aβ 
toxicity. However, the addition of both pore blockers and aggregation inhibitors simultaneously 
may eliminate the cellular dysfunction caused by Aβ. Given the common pathology associated 
with many amyloidogenic proteins, this avenue of research seems promising in light of the 
amyloid hypothesis.  
1.7  Obtaining high-resolution structures of membrane-bound Aβ species 
Due to the inability to crystallize stable and homogeneous Aβ preparations on 
membranes, the use of computational techniques has become the principal mode to model Aβ 
structure in membranes (27, 40). Yet, the details of Aβ-membrane interactions and the membrane 
disruption process are not merely of theoretical importance, but have great practical implications 
for the prevention of membrane damage by amyloidosis. Membrane damage that is primarily 
mediated by discrete ion channels can be alleviated by channel blockers designed specifically to 
plug the channels formed by toxic amyloid species. Such small molecules were designed with 
the intention of complementary binding to distinct Aβ channel structures, thereby reducing 
cytotoxic effects and strengthening the amyloid channel hypothesis (53). However, prevention of 
a non-specific mechanism involving membrane fragmentation requires a different approach 
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aimed at blocking the interaction of protofibrillar Aβ with the membrane. To accomplish this it is 
necessary to have some understanding of the interactions involved in binding of Aβ to the 
membrane in fibrillar and prefibrillar conformations and some idea of the conformation of the 
membrane-bound peptide in a given aggregation state. Unfortunately, while many of the 
mechanistic details of Aβ amyloid formation in solution remain to be determined, experimental 
evidence of structural polymorphisms involved in amyloid formation on or in a membrane 
beyond the resolution of CD, ThT fluorescence, and other biophysical measurements are almost 
completely unknown.  
Currently, the only membrane bound models of Aβ that exist are high-resolution 
structures of Aβ monomers bound to detergent micelles and computer simulations of channels or 
oligomers constructed from fragments of the Aβ fiber (27, 40, 54). The computer simulations of 
Aβ channels have been invaluable in identifying molecular features of potential Aβ pore 
structures, yet more structural data is necessary to further refine computational models and to 
collectively understand all forms of membrane disruption. It is apparent that membranes have a 
two-fold effect on Aβ: (i) membranes can greatly accelerate the rate of fibrillization and (ii) Aβ 
can directly disrupt plasma and possibly organelle membranes. The cell membrane therefore 
contributes to Aβ toxicity as both a site for the accumulation/nucleation of toxic oligomers and 
as a target for their cytotoxic effect. Consequently, it is imperative to better understand how 
environmental factors within the cell membrane (such as the lipid composition) contribute to 
structural polymorphisms of Aβ oligomers. Such data will help us understand both how 
membrane disruption occurs and possibly if certain cell types are more sensitive to Aβ toxicity 
due to an altered lipid composition, generating a more toxic conformation. 
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1.8 Experimental methods for studying the process of amyloid fibrillization and 
oligomerization  
Characterizing the kinetics of amyloid formation as well as the structural transitions that 
occur therein is experimentally challenging. The primary challenge results from the fact that Aβ 
aggregation is a highly heterogeneous process sensitive to a variety conditions; e.g. salt 
concentration, pH, and temperature. Small changes can result in the kinetics of aggregation for 
seemingly similar samples by 1-2 orders of magnitude (Fig. 1.6A), and comparable observations 
are found with other measurements such as cytotoxicity (55). One of the most common methods 
to investigate Aβ aggregation, and any amyloid forming protein in general, is through the use of 
the amyloid-specific dye thioflavin T (ThT) (Fig. 1.6A). ThT specifically binds to the cross β-
sheet structure of the long, linear fibrils and may provide indirect evidence on the conversion of 
monomers to oligomers and oligomers to fibrils (56). The ThT fluorescence response to fibril 
formation typically displays sigmoidal growth kinetics, resulting from the nucleated self-
assembly reactions. While the ThT-based fluorescence assay is robust for most amyloidogenic 
proteins, it suffers from several drawbacks that may convolute the fuller picture of Aβ 
aggregation, and amyloid aggregation broadly (57). Firstly, because the dye is amyloid-specific, 
the ThT assay provides little to no information on intermediate species that may nucleate fibril 
formation; a necessary process for fibrillization (56). Furthermore, ThT may compete with the 
same binding on the fiber structure of a small molecule inhibitor of aggregation, potentially 
giving rise to a false positive for fiber inhibition (58). Thus, complementary biophysical 
approaches are necessary, and correspondingly used in throughout this dissertation, to enable a 
comprehensive of Aβ aggregation under particular conditions.  
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A suite of biophysical techniques has been developed and is still being developed to 
dissect the Aβ aggregation. CD spectroscopy is routinely used to provide information about 
secondary structure of a particular aggregate and/or the time-course nature of the structural 
transition occurring under aggregation conditions (56, 57, 59). CD is capable of distinguishing 
monomeric species from aggregated species, in general (Fig. 1.6C); however, still suffers from a 
similar shortcoming of the ThT assay in that CD cannot distinguish between an oligomer with β-
sheet structural elements and a fibers or an oligomer lacking secondary structure and a monomer; 
the latter being true only for amyloid-forming proteins that intrinsically disordered in monomeric 
form. Light scattering methods can be used to distinguish aggregate size and may be done so in 
time-course or single time point fashion (60). However, light scattering methods fall short when 
the aggregate sizes are highly heterogeneous or too large, making such an approach limited in its 
utility as well. Separation-based approaches such as size exclusion chromatography (SEC) or gel 
electrophoresis are often employed as well (55, 61). The disadvantage with such methods stems 
from their capacity to break apart loosely associated oligomeric species and underestimates their 
actual size (61). As a result of the possible artifacts inherent to the techniques previously 
mentioned, microscopy methods, particularly atomic force microscopy (AFM) and electron 
microscopy (EM), have been invaluable to complement optical spectroscopic and separation-
based techniques (62–64). EM has been especially useful to differentiate fibril polymorphs that 
may result from different aggregation conditions (65, 66), while AFM has been a versatile tool 
for in situ imaging of aggregation (61–63). Both EM and AFM have thus far, however, been 
unable to achieve the level of resolution likely necessary to fully elucidate amyloid aggregation. 
It should be mentioned that analytical ultracentrifugation (AUC), X-ray diffraction, and small-
angle X-ray scattering (SAXS) may provide the level resolution desired, yet does not maintain 
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the temporal resolution required to perform kinetic studies of amyloid formation. Finally, NMR 
is another of the many techniques that are highly valuable to the study of amyloid aggregation 
while also having a number of advantages and some disadvantages that will be discussed in 
further detail in subsequent section (Fig 1.6B and 1.6D). 
 
Figure 1.6 Measuring the process of amyloid aggregation can be probed by many biophysical 
methods. 
(A) Thioflavin T is an amyloid-specific and is the most common way to probe amyloid formation. (B) 
Real-time NMR measurements can provide insight into the loss of monomer to higher order aggregates 
and gain of secondary structure through loss of intensity and increased spectral dispersion (indicated by 
arrows and dotted lines), respectively. (C) Time-course CD experiments demonstrate the transition from 
an unstructured monomeric state to an extended β-sheet conformation of the amyloid fibers. (D) Scheme 
describing the possible variation in aggregation pathways of Aβ40 based on different experimental data 
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depicted above. The 19F spectrum above the scheme shows peaks that correspond to various intermediates 
formed as a result of Aβ40 aggregation. Panels C and D are adapted from references X and XX, 
respectively. 
While the discussion of the plethora of biophysical techniques can be and have been used 
to study amyloid aggregation and morphology seems overall negative or unenthusiastic, it 
merely serves to demonstrate that studies involving amyloid research must encompass a wide 
array of experimental approaches to gain a full picture of the various processes occurring therein.  
1.9 Using NMR to study amyloid aggregation 
NMR has emerged as a vital tool for the structural and dynamic characterization of 
aggregate assembly (67–69), oligomer structure (9, 10, 70), and amyloid fibril structure (6, 65). 
While NMR must commonly be complemented with other biophysical approaches, it offers the 
capability to measure many of the quantities afforded by the techniques previously discussed, 
namely: (i) distinguishing monomeric, oligomer, and fibrillar species (ii) sensitivity to lowly 
populated species (iii) being non-perturbative (iv) no interference with small molecule inhibitors 
(v) achieving atomic resolution. The main disadvantage is the typical requirement for higher 
concentrations, although recent advancements in hardware have made possible the ability to 
work in the micromolar range.  
This dissertation focuses on the development and application of two distinct NMR 
methodologies each of which with distinct advantages geared towards elucidating the mechanism 
of amyloid aggregation. Approaches from both solution- and solid-state NMR are used in this 
dissertation and manner in which they are used is discussed below.  
1.9.1 Solution NMR and the application of fast acquisition NMR techniques 
Solution NMR has long been a powerful biophysical tool for high-resolution structural 
and dynamic studies of biomacromolecules. Using the intrinsic magnetic properties of atomic 
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nuclei, NMR is used to determine protein structure, internal protein dynamics, and/or transient 
protein-protein interactions. Due to the high sensitivity and high natural abundane of the 1H 
nucleus, one-dimenerionsal (1D) 1H NMR is routinely used for the characterization of small 
organic and inorganic compounds. For studies of biomacromolecules, such as proteins or nucleic 
acids, multidimensional NMR is necessary to achieve higher resolution due to spectral overlap 
resulting from the sheer quantity of 1H present. In protein NMR spectroscopy, one of the most 
widely used 2D NMR techniques used is the Heteronuclear Single Quantum Coherence (HSQC) 
experiment (Fig 1.7A) (71). HSQC uses J-coupling (i.e. through-bond coupling) to correlate a 1H 
nucleus with a directly bonded 13C or 15N nucleus. The 1H-15N/13C HSQC experiment is 
extensively used to examine protein structure and dynamics with residue specificity as function 
of any number of parameters, e.g. through changing environmental variables such as pH, salt 
concentration, temperature, or introduction of a ligand (71–73). 
 
Figure 1.7 Pulse sequences to record 1H-X correlation spectra. 
(A) The standard 1H-X HSQC experiment. The time delay τ is set to (1/2JHX). (B) The SOFAST-HMQC 
experiment. The time delay Δ is set to (1/2JHX) and trec is the recycle delay between scans. The delay δ 
accounts for spin evolution between pulses and is optimized prior to acquisition to yield pure absorption 
spectra. (A, B) Filled and open symbols indicate 90º and 180º pulses, respectively; except for the 1H 
excitation pulse applied with a flip angle α designated in the SOFAST-HMQC experiment. In panel B, the 
gray filled symbols are gradient pulses that are used to purge undesired magnetization components. Panel 
B has been adapted from ref 72.  
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With the development of fast acquisition NMR methods, namely, the SOFAST-HMQC 
(band-Selective Optimized-Flip-Angle Short-Transient heteronuclear multiple quantum 
coherence) experiment, multidimensional experiments that previously took hours are reduced to 
an acquisition time of minutes (Fig. 1.7B) (71). As a result of this reduced experimental 
acquisition time, amyloid aggregation can be studied in real time without worry of differing 
sample conditions over the course of acquisition. For example, in the case of Aβ aggregation, 
fibers can form in as little as 2 hours and oligomers can often form with several minutes (61, 74). 
The loss of monomer to a larger, potentially structured oligomer or fiber will result in loss signal 
intensity due to changing populations or chemical exchange. The time required for the 
acquisition of an n-dimensional experiment is determined by the sensitivity of a given sample, 
the number of indirectly sampled dimensions (n-­‐1), and the desired spectral resolution (71). 
What the SOFAST-HMQC experiment has done to reduce experimental is solved the problem of 
data sampling by reducing the time between scans (trec, Fig 1.7B) through enhanced longitudinal 
relaxation (achieved by band-selective 1H pulse) (71).   
Real-time NMR is a promising alternative to studying the time-course evolution of 
amyloid aggregation. Real-time 1D NMR has been previously used for Aβ and IAPP (58, 59); 
however, as mentioned previously, the lack of resolution hampers any high-resolution 
information that would otherwise be gained through 2D NMR studies. Two recent studies 
utilized single-site labeling incorporating a 19F probe to track Aβ and IAPP aggregation (58, 59). 
Intriguingly, in the case of Aβ distinct new peaks could be observed deep into the incubation (> 
50 days) and after the formation of fibers (see spectrum in Fig 1.6D). While real-time 1D NMR 
is highly useful, it is does not achieve details beyond low-resolution measurements. SOFAST-
HMQC offers the unique ability to monitor amyloid aggregation at atomic resolution without the 
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time constraints typical of most 2D NMR experiments, allowing the kinetic processes of fibril or 
oligomer assembly to be tracked with residue specificity in real-time. Further details on 
application of this methodology to can be found in Chapter 4.  
1.9.2 Magic Angle Spinning NMR and Radio frequency-driven dipolar recoupling  
Solution NMR in limited in its ability to resolve molecules based on their size. With 
increasing molecular weight, anisotropic contributions to NMR signal intensity results in 
increased linewidths and, in turn, reduced spectral resolution. In solution samples, this line 
broadening is a result of decreased molecular tumbling rates, leading to decreased sampling of 
the molecules orientations. In true solid samples, there is essentially no molecular tumbling and, 
therefore, the spectrum of such a sample results in a powder pattern (Fig. 1.8, bottom). To 
overcome the molecular weight limit imposed by static NMR, a technique called magic angle 
spinning (MAS) is used to mechanically average the anisotropic interactions inherent to such 
systems. Moreover, MAS can be used on solution samples that have solid-like characteristics 
(e.g. amyloid oligomers) to bridge the gap between limitations imposed on both solution- and 
solid-state NMR methods; the molecular weight limit in solution NMR and problems with 
sensitivity in solid-state NMR. These limitations are further overcome by taking advantage of 
both solution- and solid-state techniques: performing solid-state NMR experiments on liquid 
sample with “solid” characteristics (75). 
 
Figure 1.8 Magic angle spinning can create solution-like conditions on a solid sample. 
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Increasing MAS rates yields spectra that more closely resemble isotropic conditions. Spurious signals that 
may be attributed to an incomplete averaging by MAS appear under slow spinning conditions (middle). 
While there are number of solid-state NMR techniques that can be applied in this regard, 
this dissertation will focus only on radiofrequency-driven dipolar recoupling (RFDR) (76). 
Recoupling pulse sequences are often used in MAS NMR to reintroduce and measure anisotropic 
interactions being averaged out by MAS. In other words, we use RF pulses synchronized with 
the spinning frequency of MAS to interfere with the averaging process that it induces to recouple 
the dipole interactions (77). Dipolar recoupling methods are often used in solid-state NMR 
experiments to measure distances between nuclei and, upon doing so with appropriate 
biomolecular systems, such techniques can be used as tool for structural biology (77, 78). The 
RFDR recoupling scheme is used to measure dipole interactions of homonuclear spins, and here 
specifically studied using 1H-1H dipole interactions (Fig 1.9, top). Several groups, including 
ours, have been exploring methods to improve sensitivity in the 1H MAS NOESY experiment 
(Fig 1.9, bottom) to be used on various biological samples (26, 79–81). The RFDR-based 2D 
1H/1H correlation experiment generates longitudinal exchange of magnetization during the 
mixing to obtain isotropic chemical shift correlation spectra via coherent 1H-1H dipolar coupling 
and the NOE (80). Thus, this approach is highly useful for non-deuterated solution samples not 
readily amenable to solution NMR techniques as it takes advantage of the “residual” dipolar 
couplings inherent to such systems. The Aβ oligomer is one such system that has primarily 
evaded high-resolution due to its size.  
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Figure 1.9 Pulse sequence schemes for 2D RFDR-based (top) and NOESY (bottom) 1H/1H chemical 
shift correlation experiments. 
1.10  Dissertation objectives 
While there are countless studies demonstrating the cytotoxic nature of Aβ and the 
relationship between various Aβ aggregates and their cytotoxicity, many questions remain. 
Particularly, in this dissertation, I first explore in greater detail Aβ’s ability to bind to and disrupt 
cell membranes as a potential mechanism for cytotoxicity, paying particular attention to the role 
of membrane composition in diminishing or enhancing this effect while simultaneously 
understanding how membrane composition alters Aβ aggregation (Chapter 2) (82). Then, with 
the aim of further elucidating the Aβ aggregation pathway(s), I implement a combinational 
technique utilizing both solution- and solid-state NMR for the high-resolution characterization of 
Aβ oligomers (Chapter 3) (79). Additionally, using fast acquisition NMR techniques coupled 
with measurements of residual dipolar couplings by solution NMR, I investigate the transient, 
non-native states of the amyloid fiber elongation process (Chapter 4). These contributions are 
explored due to the fact that protofibrillar Aβ aggregates and/or the process of Aβ fibrillization 
remain probable causative or contributing agents in AD.  
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Chapter 2: Elucidating the Role of Lipid Composition on Aβ 
Aggregation and Aβ-Induced Membrane Disruption 
This chapter was adapted from the following publication:  
Sciacca, M.F.M., Kotler, S.A., Brender, J.R., Chen, J., Lee, D.K., and Ramamoorthy, A. (2012) 
Two-step mechanism of membrane disruption by Aβ through membrane fragmentation 
and pore formation. Biophysical Journal, 103, 702-710. 
 
2.1. Introduction 
Alzheimer’s disease is a devastating neurodegenerative disease characterized by memory 
loss and severe cognitive impairment. A key pathological marker of Alzheimer’s disease is the 
formation of extracellular plaques caused by the misfolding and aggregation of the Aβ40 and 
Aβ1-42 peptides into extended fibrillar structures known as amyloid (1,2).  Amyloid formation by 
Aβ40 is believed to be a key early stage in the development of Alzheimer’s, as Aβ40 aggregation 
has been repeatedly linked to neuronal dysfunction and death (3). The aggregation of Aβ40 
generates a complex, multifactorial response in neurons, leaving the actual source of Aβ40 
cytotoxicity unresolved.  A number of studies have identified several factors that may contribute 
to the pathology of Alzheimer’s disease, including the generation of reactive oxygen species 
during aggregation, excessive aggregation of misfolded proteins leading to stress in the 
endoplasmic reticulum, inflammation, disruption of cellular membrane integrity, and activation 
of cell surface receptors that lead to cell death (3).  
Although the exact mechanism by which Aβ causes neuronal death is not certain, one of 
the most clear and consistent pathologies in Alzheimer’s disease is an elevation of cytoplasmic 
 35 
Ca2+ in the vicinity of Aβ amyloid deposits (4,5). The mechanism by which Aβ stimulates Ca2+ 
influx has not been fully elucidated, but it has been suggested that Aβ can directly disrupt 
membranes through the formation of ion channels (the “channel hypothesis of Alzheimer’s 
disease”) (6,7). In the channel hypothesis, small annular oligomers of Aβ possessing a 
hydrophobic exterior and hydrophilic interior insert into the membrane, spanning the bilayer 
(8,9). The hollow structure of the oligomers allows ions to cross through the hydrophilic interior 
of the pore, causing an unregulated influx of Ca2+ into the cell. Since both neurons and 
mitochondria are highly sensitive to perturbations in ionic strength, a small perturbation in 
intracellular calcium levels caused by the unregulated Aβ channels can trigger an apoptotic 
cascade (10). 
Experimental support for the channel hypothesis largely rests on atomic force and 
electron microscopy and single channel conductance measurements.  Annular structures 
suggestive of ion channels have been directly observed by AFM when Aβ40 and Aβ1-42 is 
reconstituted into planar lipid bilayers (9). The formation of these annular structures correlates 
with single-channel ion conductance measurements which show step-wise current fluctuations 
suggestive of the formation of discrete pores (9,11-13). Like endogenous calcium channels, the 
channels formed by Aβ are charge and size selective and can be blockaded by specific molecules 
such as Zn2+ that bind to the interior of the pore (14-17). The ability of Aβ channels to be 
blockaded by Zn2+ suggests a specific structure is involved in membrane disruption rather than a 
generalized disruption of the physical integrity of the bilayer.  
 Although the channel hypothesis accounts for many facets of Aβ toxicity through 
membrane disruption, some facets remain unexplained. First, large (up to 30 nm in diameter) 
spherical aggregates of Aβ have been repeatedly found to be toxic (18-20). This finding is 
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surprising in light of the channel hypothesis, which would predict such large spherical aggregates 
could not form ion channels unless disassembled into smaller aggregates. Second, aggregation of 
Aβ is often accompanied by large-scale morphological changes in the membrane that would not 
be expected by the insertion of small oligomeric pores (21-23). Rather, these large-scale 
morphological changes suggest physical disruption of the membrane also takes place after 
prolonged incubation with Aβ, which may be a contributing or dominant factor in the toxicity of 
Aβ. It has been suggested that the elongation of existing fibrils adsorbed to the membrane can 
remove lipids from the membrane via a detergent-like mechanism, causing membrane disruption 
that could lead to cell death (24,25). However, the relationship between these two types of 
membrane disruption by Aβ and other amyloidogenic proteins has not been defined.  
We show here through the use of model membrane systems that the mechanism of Aβ 
membrane disruption in vitro is likely to be mediated by a two-step process similar to that 
proposed for IAPP:  (i) prior to fibril formation, soluble oligomers bind to the membrane to form 
small channel-like pores and (ii) Aβ fibril elongation causes membrane fragmentation through a 
detergent-like mechanism. Furthermore, we found that the fiber-dependent step of membrane 
disruption only occurred in the presence of gangliosides, whereas pore formation occurred at low 
level in the absence of gangliosides. 
2.2. Results  
2.2.1. Oligomerization of Aβ40 on the membrane strongly disrupts ganglioside-containing 
membranes.  
Membrane disruption by Aβ40 was estimated by quantifying dye leakage induced by 
Aβ40 from vesicle encapsulated 6-carboxyfluorescein (26). Previous measurements have shown 
freshly dissolved Aβ40 typically induces a very small amount of dye release for standard 
 37 
membrane compositions in comparison to other membrane disruptive proteins such as 
antimicrobial peptides (27,28). However, these experiments usually measured membrane 
disruption only for a few minutes after the addition of Aβ40 and therefore did not take into 
account the time-dependent oligomerization of the Aβ40  peptide  (27-29).  
 
 
Figure 2.1 Membrane disruption induced by Aβ40, as measured by the 6-carboxyfluorescein dye 
leakage assay.  
The graph illustrates the release of 6-carboxyfluorescein induced by 10 µM Aβ40 from 7:3 POPC/POPS 
LUVs (green line), 5:3.5:1.5 POPC/POPS/gangliosides LUVs (red line), and TBLE LUVs (blue line). 
Dye leakage occurs only after a lag period and is detected only in ganglioside-containing membranes. 
Experiments were performed at room temperature in 10 mM phosphate buffer, pH 7.4, 100 mM NaCl, 
and all LUV concentrations were 0.2 mg/ml. Results are the average of three measurements.  
 To take into account how the ongoing polymerization of Aβ40 may affect membrane 
disruption, we recorded dye leakage from model membranes over several days after the addition 
of freshly dissolved Aβ40 (Fig. 2.1). Corresponding assays using the amyloid sensitive dye 
thioflavin T (ThT) were used to measure fiber formation (Fig. 2.2). No significant leakage was 
observed from membranes composed of only POPC/POPS within two days, suggesting that 
Aβ40 does not cause membrane defects that allow the passage of 6-carboxyfluorescein in 
membranes in POPC/POPS membranes. However, membrane binding by Aβ40 is highly 
sensitive to membrane composition (30,31). To test a more physiologically relevant membrane 
composition, we performed the identical experiment with lipid vesicles formed from total lipid 
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brain extract (TLBE) with strikingly different results. Leakage from TLBE vesicles was initially 
low, similar to the leakage observed from POPC/POPS vesicles. However, leakage from TLBE 
vesicles sharply increased after a lag time of approximately 1000 minutes after the addition of 
Aβ40. The time–scale of release shares the same sigmoidal profile as amyloid formation (Fig. 
2.1-2), suggesting this second phase of membrane disruption is correlated with fiber formation. 
However, since the ThT assay measures fiber formation occurring both in solution and on the 
membrane, an exact correspondence cannot be made because of the differing sensitivities of the 
two assays.       
 
 
Figure 2.2 Kinetics of Aβ40 amyloid formation measured by ThT fluorescent emission.  
The graph shows 10 µM Aβ40 in buffer in the absence of membranes (black line) an din the presence of 
0.2 mg/ml 7:3 POPC/POPS LUVs (green line), 5.5:3:1.5 POPC/POPS/gangliosides LUVs (red line), or 
TBLE LUVs (blue line). Experiments were performed at room temperature in 10 mM phosphate buffer, 
pH 7.4, 100 mM NaCl. Results are the average of three measurements. 
The dye release assay shows Aβ40 is substantially more efficient at disrupting TBLE 
vesicles than PC/PS vesicles. The TLBE is a complex mixture of lipids containing a variety of 
phospholipids, cholesterol, sphingolipids and gangliosides. Gangliosides in particular may be 
important for membrane disruption, as several studies have shown binding to the membrane 
surface is strongly enhanced by the ganglioside content (27,32-35). In addition, fiber formation is 
greatly accelerated by the presence of gangliosides, which may affect an oligomerization 
dependent process (25,32,36-41).  
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To test if the presence of ganglioside contributed to membrane disruption by oligomeric 
Aβ40, we performed the same dye leakage experiment using a simpler model membrane system 
(POPC/POPS/total ganglioside extract, molar ratio 5.5/3/1.5) containing an amount of 
ganglioside similar to that found in the total lipid brain extract. The results for this sample 
resemble the results obtained from total lipid brain extract (Fig. 2.1, red line), confirming that the 
presence of ganglioside in the membrane is sufficient for membrane defects that allow the 
passage of 6-carboxyfluorescein.  
2.2.2. Cation-selective pores form immediately upon addition of Aβ to all membrane 
types.  
The carboxyfluorescein assay suggests membrane disruption after the addition of Aβ40 is 
initially low but becomes higher after oligomerization begins. While this finding is consistent 
with the well-known toxicity of protofibrillar Aβ, many conductance studies in planar lipid 
bilayers have shown channel-like activity occurring immediately after the addition of freshly 
dissolved Aβ40 (42-46), well before the appearance of fibers (47,48). In addition, the pores 
detected by electrical recording are cation-selective (6-carboxyfluorescein is negatively charged) 
and are predicted through AFM measurements to have an inner diameter of 2 nm, which may be 
too small to allow efficient passage of the 6-carboxyfluorescein molecule (9,49-51). This raises 
the possibility that Aβ40 quickly forms pores in the membrane, but the pores are not detected by 
the 6-carboxyfluorescein dye leakage assay due to the size or charge of the molecule. 
 To test this possibility, we measured the influx of calcium ions into the LUV using 
vesicle encapsulated calcium sensitive Fura-2 dye. Calcium ions are smaller than 6-
carboxyfluorescein (the Stokes radius of the hydrated calcium ion is 0.3 nm compared to 0.7 nm 
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for fluorescein) (52,53) and positively charged, and therefore measurements of Ca2+ influx more 
directly correspond to conductance measurements on planar lipid bilayers.  
 
 
Figure 2.3 Ca2+ influx into LUVs after the addition of freshly dissolved Aβ40.  
The maximum values of Ca2+ ion influx detected by encapsulated Fura-2 after 30 min of incubation with 
freshly dissolved Aβ40 from 0.2 mg/ml of TBLE LUVs (dark gray bars) or 7:3 POPC/POPS LUVs (light 
gray bars) are shown. In contrast to the 6-carboxyfluorescein due release assay, Ca2+ influx occurs 
shortly after the addition of Aβ40 and occurs weakly in the absence of gangliosides. The antimicrobial 
peptide MSI-78 was used as a reference for total disruption of membranes (black bars).  
Fig. 2.3 shows the calcium influx obtained 30 minutes after incubation with Aβ40. Influx 
of Ca2+ occurs immediately after the addition of the peptide (within 10 minutes), well before 
membrane disruption as measured by the 6-carboxyfluorescein measurement (Fig. 2.1) and fiber 
formation as measured by ThT fluorescence (Fig. 2.2). The amount of influx induced by Aβ40 in 
TLBE vesicles is significant, but less than that induced by the strongly membrane disruptive 
antimicrobial peptide MSI-78 which completely disrupts the membrane at equivalent 
concentrations (Fig. 2.3) (54). Interestingly, we detected calcium influx in POPC/POPS LUVs, 
which do not contain gangliosides (Fig. 2.3, light gray bars), although the amount is less than 
that observed for the total brain extract LUV. This finding is in contrast to the 6-
carboxyfluorescein assay in which membrane disruption of POPC/POPS LUVs is negligible 
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even after prolonged incubation. The small but measureable Ca2+ influx in POPC/POPS LUVs 
suggests that the presence of ganglioside enhances the formation of cation-selective small pores 
by the peptide, but is not absolutely essential for their formation. 
2.2.3. Zinc ions can block early permeabilization by pores but not fiber-dependent 
membrane disruption.  
To confirm calcium influx is correlated with the formation of small pores similar to those 
detected by electrical recording in planar bilayers, we repeated the previous experiment using 
Zn2+ ions instead of Ca2+. The ability of Zn2+ to block the activity of the Aβ40 peptide  channel in 
single channel conductance measurements has been well established (13,50,55-57) and is 
believed to result from the specific binding of Zn2+ to His-13 and His-14 in the interior of the 
channel (58). Accordingly, Zn2+ is not expected to penetrate into LUVs if the pores detected by 
the Fura-2 assay are similar to those detected by single channel recording.  
Fig. 2.4 shows a comparison of the results obtained with Fura-2 assay using calcium ions 
(red line) and zinc ions (blue line). While we clearly observed influx of Ca2+ inside the LUV 
immediately after the addition of Aβ40, we did not observe any influx of Zn2+. Since Fura-2 
binds Zn2+ more tightly than Ca2+ (59) and MSI-78 permits influx of both Ca2+ and Zn2+ (Fig. 
A.1), this result indicates that Zn2+, unlike Ca2+, is unable to penetrate into the interior LUV 
despite the similar charge and size of both ions. This finding suggests that the first step of 
membrane disruption involves the formation of small-sized pores similar to those detected by 
single channel electrical recording. 
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Figure 2.4 Zn2+ inhibits the pore activity of freshly dissolved Aβ40.  
The graph shows the influx of Ca2+ (red line) and Zn2+ (blue line) ions induced by Aβ40 on 0.2 mg/ml 
of TBLE LUVs. Freshly dissolved Aβ40 was added to each sample at time zero. Ca2+ or Zn2+ was added 
at 600 s as indicated by the dashed line. Fura-2 is sensitive to both Zn2+ and Ca2+ ions, as indicated by a 
control experiment performed with MSI-78 (Fig. S1.4). 
 As mentioned above, membrane disruption is initially selective for Ca2+ over 
carboxyfluorescein; however, becomes nonselective as time progresses (compare Fig. 2.1 and 
2.3). This finding implies two distinct mechanisms are operational in membrane disruption by 
Aβ40. To verify that the mechanism underlying the second step of membrane disruption is 
different from the initial pore formation and to demonstrate it involves fiber growth on the 
surface of the bilayer, we measured the influx of ions into the LUV caused by fiber elongation by 
adding freshly dissolved Aβ40 to the solution after incubation of the model membrane with 
preformed fibers. As expected, mature preformed fibers, which do not disrupt membranes (35), 
did not induce the influx of Ca2+ into TLBE LUVs (Fig. 2.5, black line) by themselves. When the 
reaction is seeded with pre-formed fibers of Aβ40, the LUVs became permeable to both Ca2+ and 
Zn2+. This finding indicates that the elongation of the amyloid fibers on the membrane surface 
disrupts membranes by a mechanism different from that initially observed when freshly 
dissolved Aβ40 is added to the membrane, since the defects in the membrane caused by fiber 
elongation are permeable to Zn2+. 
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Figure 2.5 Zn2+ ions cannot block the fiber-dependent step of membrane disruption.  
The figure shows the influx of Ca2+ (red line) and Zn2+ (blue line) ions induced by adding freshly 
dissolved Aβ40 to 0.2 mg/ml of TBLE LUVs incubated with preformed fibers. Freshly dissolved Aβ40 
was added to each sample at time zero, and Ca2+ and Zn2+ was added 600 s as indicated by the dashed 
line. No Ca2+ influx was detected after the addition of preformed fibers alones (black line). The influx of 
bot Ca2+ and Zn2+ ions (red and blue lines, respectively) were detected by seeding Aβ40 fiber formation 
with preformed fibers. This finding suggests that the fiber-dependent step of membrane disruption is not 
well correlated with pore formation. 
2.2.4. Fiber-dependant membrane disruption occurs by a detergent-like mechanism.  
The Fura-2 assay did not allow us to determine how membrane disruption by fiber 
growth occurs. For other amyloidogenic peptides, it has been demonstrated that fiber growth is 
associated with the extraction of lipids from the membrane surface, resulting in the complete 
fragmentation of the membrane (60,61). Thus, one of the possible mechanisms to explain the 
fiber-dependent step of membrane disruption by Aβ40 is a detergent-like mechanism 
characterized by the fragmentation of the membrane into peptide-lipid micelles or vesicles 
without the appearance of defined pores.  
To test this hypothesis we incubated LUV samples with Aβ40 for two days, centrifuged 
the samples to sediment intact LUVs, and then measured lipid concentrations in the supernatant 
by the Stewart assay (62). Fiber formation is expected to be complete within the two day 
incubation time (Fig. 2.2). For samples without Aβ40 (black bars in Fig. 2.6), only a small 
percentage of the total lipid concentration could be found in the supernatant, confirming almost 
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all of the lipids had pelleted after centrifugation and lipids in the supernatant are likely to be the 
result of membrane fragmentation by Aβ40. Incubation with Aβ40 caused significant membrane 
fragmentation only of ganglioside-containing membranes (Fig. 2.6). For the POPC/POPS LUV 
samples (Fig. 2.6, light gray bar), the addition of Aβ40 did not elevate the soluble fraction of 
lipid, in agreement with the lack of carboxyfluorescein release from this sample (Fig. 2.1). This 
finding suggests that membrane disruption by fiber elongation may occur by a detergent-like 
mechanism. Moreover, this result also matches with the 6-carboxyfluorescein dye leakage assay 
showing that membrane disruption occurs only if ganglioside is present in the membrane 
composition. 
 
 
Figure 2.6 Membrane fragmentation induced by prolonged incubation with Aβ40.  
Lipid concentrations in the supernatant after centrifugation from TBLE LUVs (dark gray) and 5.5:3:1.5 
POPC/POPC/gangliosides LUVs (gray) after incubation with Aβ40 fir 48 h are shown. The failure of 
lipids to sediment is an indication of their removal from bilayers to form micelle-like structures. No 
significant lipids were detected in the supernatant of samples from 7:3 POPC/POPS LUVs (light gray), in 
agreement with the dye leakage assay (Fig. 1). Results are the average of three independent measurements 
and error bars represent their standard deviation. Black bars indicate controls without peptide.  
The formation of small micelle-like lipid structures that are characteristic of a detergent-
like mechanism can also be detected by using 31P solid-state NMR (34,61). Fig. 2.7 shows the 
31P spectra obtained for POPC/POPS and POPC/POPS/Ganglioside LUVs before and after the 
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addition of Aβ40. In each experiment, a 31P spectrum of the LUVs was collected before and after 
the addition of Aβ40. In the absence of Aβ40, both samples show resonances around -13 ppm 
and -17 ppm originating from PS-rich and PC-rich lipids in the flat lamellar phases, respectively. 
An isotropic peak suggesting the formation of small micelle-like lipidic structures appears only 
in the sample containing ganglioside 10 hours after the addition of Aβ40 (Fig. 2.7B). The 
corresponding POPC/POPS LUV sample does not show an isotropic peak (Fig. 2.7A), matching 
the results of the sedimentation assay (Fig. 2.6). 
 
 
Figure 2.7 31P solid-state NMR of LUVs incubated with Aβ40.  
31P chemical shift spectra of LUVs composed 7:3 POPC/POPS (A) and 5.5:3:1.5 
POPC/POPS/gangliosides (B) before (blue) and after the additionf of Aβ40 (red) are illustrated. The small 
peak near 0 ppm in the ganglioside containing spectra indicates the formation of small, rapidly tumbling 
lipid structures indicative of membrane fragmentation. The absence of a corresponding peak for samples 
without ganglioside is an indication that membrane fragmentation does not occur. All spectra were 
obtained at 37 ºC and referenced with respect to 85% H3PO4 at 0.0 ppm.  
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2.2.5. Paramagnetic quenching NMR experiments suggest that pores disappear after fiber 
formation.  
To test for the integrity of the membrane after fiber formation is complete we employed 
paramagnetic quenching NMR experiments. Paramagnetic quenching experiments reveal the 
exposure of the lipid headgroup to solvent: if a headgroup is exposed to Mn2+ the corresponding 
resonance is broadened and the intensity decreases.  If the membrane is intact only the outer 
leaflet will be broadened, as the Mn2+ ions cannot pentrate into the membrane to quench the 
inner leaflet. If pores or other defects are present that allow Mn2+ to pass through the membrane, 
both leaflets will be broadened to some degree. Interestingly, when adding Mn2+ to the sample 
containing Aβ40 incubated for 4 days the intensity of the main resonance is reduced only by 50% 
(Fig. 2.8B), suggesting that only the headgroups of lipids in the outer leaflet of the bilayer are 
exposed to the quencher. The resonance corresponding to the isotropic phase is completely 
quenched, as is expected for a micelle-like structure. By contrast, the intensity of the resonances 
corresponding to both the lamellar and isotropic phases decrease nearly 100% after addition of 
the pore forming peptide MSI-78 (Fig. 2.8A).  The absence of an effect of Mn+2 on the lamellar 
phase in the Aβ40 sample is an indication the membrane reseals after fiber formation without 
defects that allow the passage of Mn+2 through the membrane.  
2.3. Discussion 
Although it is widely accepted that disruption of the integrity of the plasma and possibly 
mitochondrial membranes contributes to the toxicity of amyloidogenic peptides, the mechanism 
underlying this process is still not completely understood. We demonstrate here that the 
membrane disruption caused by Aβ40 is a two-step process involving initial selective disruption 
of the membrane by pores followed by non-selective physical disruption during fiber formation. 
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A similar two-step process involving fiber-dependent and non-fiber dependent steps has been 
suggested for the related amyloidogenic peptide IAPP, suggesting the mechanism by which the 
two peptides disrupt the membrane may be similar (26,63).  
 
 
Figure 2.8 Absence of membrane defects after fiber formation as detected by paramagnetic 
relaxation enhancement.  
(A and B) 31P chemical shift spectra of 5.5:3:1.5 POPC/POPS/gangliosides LUVs before (top), after the 
addition of MSI-78 (A) and Aβ40 (B) (middle), and after the addition of 500 µM Mn2+ (bottom). Mn2+ 
completely quenches the peaks originating from both the isotropic and lamellar phases in the MSI-78 
sample; however, only does so to the isotropic peak in the Aβ40 sample, indicating the absence of 
membrane defects after fiber formation is complete. Aβ40 was allowed to incubate on the membrane for 4 
days before acquisition. All spectra were collected at 37 ºC and referenced to 85% H3PO4 at 0.0 ppm.  
The initial step of membrane disruption by Aβ40 in LUVs shares many properties with 
the channels detected by single channel recording. First, membrane disruption is detected in both 
cases rapidly after the addition of freshly dissolved Aβ40. In LUVs, influx of Ca+2 occurs 
immediately after the addition of Aβ40 (Fig. 2.4). This compares favorably with single channel 
recordings and live cell calcium imaging studies, which show the influx of Ca+2 can occur 
several minutes after the addition of Aβ40 (13,64). Second, both the channels observed in single-
channel recording and the pores initially observed in LUVs are charge selective (44). In LUVs, 
membrane disruption is initially characterized by the influx of positively charged Ca2+ (Figs. 2.3 
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and 2.4) and not the negatively charged 6-carboxyfluorescein into the LUV (Fig. 2.1); despite 
their relatively similar sizes. Finally, channel activity in supported lipid bilayers and the initial 
phase of membrane disruption in LUVs can both be stopped by the addition of Zn2+ (Fig. 2.4), 
most likely through the interaction of Zn2+ with His-13 and His-14 located in the inner part of the 
channel (13,50,55-58). This finding suggests pores of a specific structure are likely to be 
involved in both experiments.  
The second phase of membrane disruption is distinguished by the leakage of 6-
carboxyfluorescein from the vesicles. Initially, Aβ40 proteoliposomes of all membrane 
compositions are impermeant to 6-carboxyfluorescein (Fig. 2.1), and leakage can only be 
detected after a significant lag-time in a manner reminiscent of fiber formation (Figs. 2.1 and 
2.2). A direct link between fiber formation and membrane disruption is suggested by seeding 
experiments, which show that membrane disruption is immediately apparent after the addition of 
freshly dissolved Aβ40 to preformed fibers (Fig. 2.5).  
While early membrane disruption in LUVs appears to share many properties with the 
channels detected by single channel recording, later membrane disruption differs markedly from 
both. First, later membrane disruption is largely non-selective for the passage of molecules. 
While both channels detected by electrical recording and the early phase of membrane disruption 
are selective for the passage of cationic molecules, the membrane becomes permeable to both 
negatively charged 6-carboxyfluorescein and Ca2+ as time progresses. The lack of selectivity in 
the second phase is consistent with a total loss of the physical integrity of the membrane, 
resulting in the appearance of small micelle-like structures as time progresses (Figs. 2.6 and 2.7). 
Second, membrane damage by fiber elongation is not stopped by the addition of Zn2+ (Fig. 2.5). 
If anything Zn2+ appears to enhance fiber dependent membrane disruption (Fig. 2.5). Finally, the 
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second phase is completely dependent on the presence of ganglioside. While early pore 
formation is enhanced in ganglioside containing membranes (Fig. 2.3), membrane fragmentation 
by fiber elongation cannot be observed at all in the absence of ganglioside (Figs. 2.6 and 2.7). 
All of these factors suggest a second process can also disrupt membranes that is not detected in 
channel recording, most likely due to the breakage of the membrane correlating with the 
formation of large membrane-bound Aβ40 oligomers (65). However, these findings are 
consistent with earlier 31P NMR and AFM results suggesting the eventual disintegration of 
membranes by Aβ40 (23,34). 
We cannot distinguish on the basis of our data if the two phases of membrane disruption 
are truly two separate and independent processes or if they are a single process with several 
stages.  Several researchers have noted that the pores formed by Aβ40 appear to be unstable. 
Instead, pores formed by Aβ40 appear to be dynamic with subunits of the pore breaking off and 
coalescing into larger, extended, and ThT-positive aggregates (65,66). The formation of these 
larger aggregates is correlated with a large change in conductance that is in agreement with the 
start of a second phase of membrane detected in our measurements (65). Furthermore, we show 
that membrane disruption by Aβ40 is transient and is abolished after fiber formation is complete 
(Fig. 2.8), suggesting the possibility that pores are converted into fibers during the membrane 
disruption process that eventually detach form the membrane. Nevertheless, it is difficult to 
resolve this question using ensemble techniques that cannot follow individual oligomers on the 
membrane throughout the aggregation process.  
 Synthetic model membranes have the advantage of being able to simplify a 
complex system, enabling us to test our hypothesis under controlled conditions. Although the 
model membranes used here are a simplification of the complex nature of biological membranes, 
 50 
our data could be useful to better understand the mechanism underlying the toxicity of Aβ 
peptide to neurons. For example, it would be highly interesting to test the synergistic effects of 
channel specific blockers such as the NA4 hexapeptide with inhibitors of fiber elongation in 
inhibiting Aβ (67,68). Experiments are underway to test this hypothesis.  
2.4. Materials and Methods 
2.4.1. Materials:  
Aβ40 (97% purity) was purchased from Anaspec (Fremont, CA ). 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
sodium salt (POPS), Total Ganglioside Extract (Brain, Porcine-Ammonium Salt), and Total 
Brain Lipid Extract were purchased from Avanti Polar lipids Inc. (Alabaster, AL). Ferric 
chloride hexahydrate, ammonium thiocyanate, and Fura-2 pentapotassium salt were purchased 
from Sigma-Aldrich (St.Louis, MO). 6-Carboxyfluorescein was purchased from Fluka.  
2.4.2. Peptide preparation. 
In order to break up any preformed aggregates, Aβ40 was initially dissolved in NH3 2%v/v 
at a concentration of 1 mg/ml.  The peptide was then lyophilized overnight and the powder 
obtained was dissolved in DMSO to a final concentration of 500 µM. Stock solution of Aβ40 
was used immediately after preparation.  
2.4.3. Model membrane preparation.  
Large unilamellar vesicles (LUV) of POPC/POPS 7/3, POPC/POPS/ganglioside 
5.5/3/1.5, and total lipid brain extract (TLBE) were prepared from a chloroform solution of lipids 
in the desired ratio. The solution was gently dried under nitrogen flow and then placed under a 
high vacuum overnight to further evaporate any residual solvent. The obtained lipid film was 
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rehydrated with a buffer solution (10 mM phosphate buffer solution, pH 7.4, 100 mM NaCl), to 
yield a final concentration of 4 mg/ml, and dispersed by vigorous stirring. The resulting solution 
was extruded 23 times through a 100 nm polycarbonate Nucleopore membrane filter (Whatman) 
mounted on a mini-extruder in order to obtain LUV with an average diameter of 100 nm.  
To prepare dye-filled LUV, the dry lipid film was hydrated with a buffer solution 
containing 6-carboxyfluorescein (10 mM phosphate buffer solution, 70 mM 6-
carboxyfluorescein, 100 mM NaCl, pH 7.4) or 100 µM Fura-2 pentapotassium salt (10 mM 
Hepes buffer solution, 200 µM EGTA, 100 mM NaCl,  pH 7.4) to a final concentration of 10 
mg/ml, which was followed by the procedures described above. Removal of any non-
encapsulated 6-carboxyfluorescein or Fura-2 pentapotassium salt was performed by running the 
extruded LUV solution through a Sephadex G50 gel exclusion column (Sigma-Aldrich) and 
collecting the first colored band detectable under visible or UV light which contained the 
separated dye-containing vesicles. The final lipid concentrations were measured using the 
Stewart assay. All solutions were freshly prepared before each experiment. 
2.4.4. Dye leakage assay.  
Membrane leakage experiments were carried out using 6-carboxyfluorescein-filled LUV 
composed of POPC/POPS 7/3, POPC/POPS/gangliosides 5.5/3/1.5 and total brain extract. 
Membrane leakage was detected by measuring the increase in fluorescence 6-carboxyfluorescein 
resulting from its dilution and subsequent dequenching following membrane leakage. Samples 
were prepared by first diluting the dye-filled vesicles solution with buffer solution (10 mM 
phosphate buffer solution, 100 mM NaCl, pH 7.4) to a final concentration of 0.2 mg/ml. The 
presence of 100 mM NaCl in the buffer ensured that the osmotic pressure exerted on the 
membrane bilayer by the dye itself had no effect on dye release from the vesicles. The NaCl 
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concentration was optimized by varying the NaCl concentration in the buffer outside the LUVs 
until baseline leakage in the absence of peptide was negligible over several days. To initiate 
membrane disruption, 1 or 2 µl of the peptide stock solution was added to 100 µl of the LUV 
solution to obtain a final peptide concentration of 5 or 10 µM , respectively. Experiments were 
carried out in Corning 96 well non-binding surface plates. Time traces were recorded using 
Biotek Synergy 2 plate reader using a 2 nm bandpass filters at 494 nm excitation and 520 nm 
emission at room temperature, shaking samples for 10 seconds before each read. The fraction of 
dye released was calculated by: 
Fraction of dye released = (I -I0)/(I100 - I0) 
where I is the emission intensity of the sample, I0 is the emission intensity obtained in the 
absence of peptide (baseline control) and I100 is the emission intensity obtained after adding 1 µl 
of Triton X-100, a detergent which acted as a positive control to give 100% leakage.  
2.4.5. ThT assay.   
The kinetics of amyloid peptide formation were measured through increased fluorescence 
emission upon binding of amyloid fibers to the commonly used amyloid specific dye, thioflavin 
T (ThT). Samples were prepared by adding 1 or 2 µl of the peptide stock solution to 100 µl of the 
10 mM phosphate buffer solution ( 100 mM NaCl, pH 7.4 containing 10 µM ThT) containing 0.2 
mg/mL LUV prepared in the same manner as above, to yield a final peptide concentration of 5 or 
10 µM, respectively. Experiments were carried out in Corning 96 well nonbinding surface plates 
as detailed for the 6-carboxyfluorescein assay using a 440 nm excitation filter and a 485 nm 
emission filter.  
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2.4.6. Fura-2 assay.  
The presence of cation or size selective pores was detected by measuring changes in the 
340/380 nm excitation ratio upon binding of Ca+2 or Zn+2 to the cation sensitive dye Fura-2 
encapsulated within the LUVs. Samples were prepared by first diluting the Fura-2 dye-filled 
vesicles solution with buffer solution (10 mM Hepes buffer solution, 100 µM Fura-2 
pentapotassium salt, 200 µM EGTA, 100 mM NaCl,  pH 7.4) to a final concentration of 0.2 
mg/ml. Then, Aβ40 was added with a final concentration of 5 µM or 10 µM. Fluorescence was 
measured at 340 and 380 nm with slits set for 10 nm bandwidths to obtain the baseline. After 10 
minutes, 500 µM of Ca+2 or Zn+2 was added to the sample and changes in the 340/380 ratio were 
recorded. Samples with MSI-78, an antimicrobial peptide that is known to strongly disrupt 
membranes, were also run as a positive control.  
2.4.7. Lipid sedimentation assay.  
The presence of micelle formation was detected measurement of lipid concentration in 
the supernatant following sedimentation of 1000 nm LUVs by centrifugation.Solutions of 
POPC/POPS 7/3, POPC/POPS/Ganglioside 5.5/4/1.5, and total brain extract LUV and final 
concentration of 1 mg/ml were prepared as described above except extrusion was performed 
through 1000 nm membranes. 20 µM Aβ40 was first incubated with 250 µl of the LUV solution 
for 2 days in order to form amyloid fibers. Following incubation with Aβ40, samples were then 
centrifuged for 40 minutes at 14000 rpm and the supernatant, which contained any micelles, was 
collected, diluted in 1 ml of chloroform, and treated as described below in order to measure the 
lipid concentration in solution. Solutions without Aβ-40 were set as controls. 
Lipid concentrations in the supernatant were detected via the Stewart assay, a 
colorimetric technique based on the ability of phospholipids to form a complex with ammonium 
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ferrothiocyanate. Initially, a calibration curve was created for each LUV lipid composition. A 
series of chloroform solutions with known concentrations of lipids (each solution 1 ml) were 
prepared and treated with 1 ml of a solution containing ferric chloride and ammonium 
thiocyanate. Each solution was vortexed for 20 seconds and the organic phase collected. The 
optical density of these standard solutions was at 461 nm and plotted versus the known lipid 
concentration and used as a calibration curve to determine the lipid concentrations in the 
supernatant. 
2.4.8. 31P solid state NMR.  
All of the experiments were performed on a Varian Infinity 400 MHz solid-state NMR 
spectrometer operating at resonance frequencies of 400.139 MHz and 161.976 MHz for 1H and 
31P nuclei, respectively. A 5 mm double-resonance MAS probe was used for experiments on 
LUVs under static conditions. A Varian temperature control unit was used to maintain the 
sample temperature at 37 oC. All the 31P spectra were collected using a spin echo sequence (90o-
delay-180o with 60 µs delay) and 25 kHz RF field for TPPM decoupling of protons. A typical 
90o pulse length of 5 µs was used with a recycle delay of 3 seconds. The 31P chemical shift 
spectra are referenced with respect to 85% H3PO4 at 0 ppm. In each experiment, the 31P spectrum 
of 200 µL LUVs composed of 4 mg POPC/POPS or POPC/POPS/Ganglioside was first collected 
in a 5 mm NMR tube. Following the acquisition of the control spectrum without peptide, 20 µL 
of 0.3 mg/ml Aβ40 or 0.1 mg/ml MSI-78 was added into the same NMR tube and acquisition 
immediately repeated to obtain the spectra of the membrane in the presence of 0.5 wt % MSI-78 
or 1.6 wt % Aβ40. Each spectra is composed of 25000 scans for a total acquisition time of 21 
hours. Aβ40 was then allowed to incubate on the membrane for three days before 500 µM MnCl2 
was added for the paramagnetic quenching experiments.  
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Chapter 3: Characterizing Structural Features of Amyloid-β 
Oligomers Through Combined Approaches in Solution- and Solid-
State NMR 
This chapter was adapted from the following publication:  
Kotler, S.A., Brender, J.R., Vivekanandan, S., Suzuki, Y., Yamamoto, K., Krishnamoorthy, J., 
Walsh, P., Cauble, M., Monette, M., Banaszak Holl, M.M., Marsh, E.N.G., and 
Ramamoorthy, A. (2015) High-resolution NMR characterization of low abundance 
oligomer of amyloid-β without purification. Scientific Reports, 5, 11811; doi: 
10.1038/srep11811. 
 
3.1. Introduction 
Alzheimer’s disease (AD) is a fatal neurological disorder affecting more than five million 
people in the United States today; a figure that is expected to increase three-fold by 2050 if 
therapeutics remain inadequate (1). Although the exact cause of AD remains undetermined, 
many signs point to the involvement of the aggregation of the amyloid-β (Aβ) peptide at some 
stage (2, 3). The aggregation of Aβ leads to the formation of senile plaques found in patients 
with AD, the main constituent of which is the Aβ peptide in its fibrillar form (4). However, 
attempts at pharmaceutical intervention aimed at targeting Aβ aggregation has been complicated 
by the myriad forms that aggregates of Aβ can adopt, many of which remain poorly 
characterized (3, 5, 6). 
Much effort has been undertaken in the way of understanding the structural details of the 
monomeric (7–9) and fibrillar (10–13) forms of Aβ both computationally and experimentally; 
however, there are only few existing structural models of the intermediates formed along the 
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misfolding pathway of Aβ (14–17). Unfortunately, these are the species currently believed to be 
most critical for pathogenesis in Alzheimer’s and other amyloid related neurodegenerative 
diseases (3). Most of the models that do exist bear a close structural resemblance to the fiber end-
product (15, 18–20), with few exceptions (21). However, considerable evidence from lower-
resolution techniques like CD suggests some (but not all) of the most toxic oligomers may have a 
considerably different structure that may be closer to the Aβ monomer than the Aβ fiber (22–25). 
The transient nature and high heterogeneity of amyloid oligomers present significant 
challenges for high-resolution structural studies. Oligomers of a specific conformation are 
difficult to isolate, which has thus far severely limited high-resolution characterization of Aβ. 
Moreover, oligomer structures of Aβ40 and Aβ42 have not been obtained by crystallography 
(only a low resolution structure of a specific Aβ oligomer obtained by powder X-ray diffraction 
and modeling exists) (26), nor have they been obtained for oligomers of other amyloidogenic 
proteins, except for αB-crystallin (27).  
Previous studies have shown Aβ40’s ability to form unordered, globular aggregates with 
little to no secondary structure (22, 24, 25, 28). Not only are these oligomers a critical step in the 
aggregation of Aβ, but they also exhibit a high degree of cytotoxicity (22, 24, 25). A time 
dependent 19F NMR study showed that such oligomers can persist even after prolonged 
incubation (>50 days) and the formation of amyloid fibrils (29); however, none of these studies 
demonstrated structural details beyond low-resolution measurements. To characterize the 
disordered globular oligomers, we chose experimental conditions similar to these previous 
studies using low salt concentrations and neutral pH, yet here we also apply agitation during 
seeded fibrillization. This method of preparation results in the formation of an aggregated Aβ 
sample comprised mostly of fibrils with a small population of a predominantly disordered 
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oligomeric species of Aβ40. Remarkably, this method of preparation yielded disordered 
oligomers reproducibly at almost 10% of the total peptide concentration without perturbative 
methods, such as chemical- or photo-crosslinking, freezing, amino acid substitution, or any other 
type of protein engineering to stabilize the oligomer. 
Using magic angle spinning (MAS) NMR spectroscopy on these samples, we are able to 
resolve structural details otherwise unobservable by other biophysical measurements. We do so 
by bridging the gap in the limitations imposed on solution- and solid-state NMR methods; a 
molecular weight limit in solution NMR and problems with sensitivity in solid-state NMR. These 
limitations are overcome by taking advantage of both solution- and solid-state NMR techniques: 
performing solid-state NMR experiments on a liquid sample with “solid” characteristics. A 
similar approach was taken with a solution sample of Aβ by monitoring the formation and 
kinetics of large aggregates sedimenting out of solution (30). However, this technique used 13C 
detection requiring large amounts of sample and expensive, isotopic labeling.  
Here, we employ a RFDR (radio frequency driven dipolar recoupling)-based 2D 1H/1H 
chemical shift correlation experiment to overcome these limitations (31). High-resolution 
structural features of high molecular weight oligomers are difficult to characterize directly by 
solution NMR; however, the RFDR-based 2D 1H/1H experiment enables the specific detection of 
this oligomeric species over fibrillar and monomeric Aβ40 due to the line-narrowing afforded by 
slow MAS and the reintroduction of residual 1H/1H dipolar couplings by RFDR. Previously, the 
applicability of RFDR for the study of such “soft” solid systems was used to investigate the 
structural and motional characteristics of a resin-bound peptide (32), a micelle-associated 
cytochrome b5 (33), and membrane-bound peptides (34–36). Here, we demonstrate the utility of 
1H/1H RFDR for the specific structural characterization of a minority population of a stable, 
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disordered Aβ40 oligomer containing sparse secondary structure, at low abundance, directly 
from an unlabeled sample in coexistence with amyloid fibrils without further purification or 
filtration. To the best of our knowledge, this is the first instance in which 1H/1H dipolar 
couplings have been used for structural studies of an amyloid oligomer, which may provide a 
general method to study intermediate size oligomers of the type believed to play a crucial role in 
amyloid pathology (3). 
3.2. Results and Discussion 
Aβ40 can form a disordered oligomer in parallel with β-sheet fibrils. Since intermediate 
size (<100 kDa) oligomers have been a prime target of both pharmaceutical and scientific 
research (3), we first sought to find a condition that allowed the reproducible generation of 
oligomers of this type. Our previous study utilizing real-time observation of a single-site 19F-
label at the Met-35 of Aβ40, found that Aβ40 oligomers are observed and stabilized well into the 
late stages of the aggregation process (29). In agreement with Suzuki et al, we find the 
coexistence of oligomers and fibers in our samples; however, the oligomers formed under our 
shaking conditions are not of the β-sheet type. A CD spectrum (Fig. 3.1a, solid) shows an 
intensity minimum at 225 nm indicating the bulk sample is predominantly β-sheet. Using size-
cutoff filtration with a Spin-X 0.22 µm filter, we could isolate the oligomers and any residual 
monomers from the fibrils of Aβ40. A noticeably different CD spectrum is apparent in the 
filtrate, which shows a strong minimum near 198 nm indicative of a predominantly disordered 
structure (Fig. 3.1a, blue) very similar to that of early aggregation states of Aβ (Fig. 3.1a, red). 
We further confirmed the lack of β-sheet content of the filtered Aβ40 oligomers using the 
amyloid-specific dye, ThT (Fig. 3.1b). Similar to the freshly dissolved Aβ40 sample, the 
oligomers isolated by spin-X filtration display essentially no fluorescence in its ThT emission 
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profile, indicating a β-sheet conformation is not present  (Fig. 3.1b). Conversely, an intense ThT 
signal is present in the isolated fibril fraction. Measuring the concentration of the spin-X filtrate 
by the bicinchoninic acid (BCA) protein concentration assay (Thermo Scientific) revealed 17.0 ± 
6.0 µM or only 7.3+2.6% of the total Aβ40 concentration (231 µM) was not fibrillar. Together, 
the ThT, CD, and BCA results confirm the sample primarily consists of amyloid fibrils with a 
minority population of a largely disordered, relatively low MW species. 
 
 
Figure 3.1 Biophysical characterization of Aβ40 disordered oligomers.  
(a) CD spectra, (b) ThT fluorescence, and (c) bis-ANS fluorescence of fibrillar (black), the spin-X 
isolated oligomer (blue), and freshly dissolved (red) samples of Aβ40. In panel c, the emission spectrum 
of bis-ANS in solution is shown in gray. (d) Distributions of hydrodynamic radii of freshly dissolved 
Aβ40 (red) and spin-X-isolated Aβ40 oligomers (blue) determined by DLS. Representative AFM and 
TEM images of the oligomers (e) and fibrils (f), respectively. Scale bars in both images are 100 nm. All 
experiments were performed in 10 mM phosphate buffer, pH 7.4, at 25 ºC.  
 Since the CD spectra of the spin-X filtrate resemble CD spectra of monomeric 
Aβ, it is possible that the filtered sample consists of residual monomeric Aβ40. We first tested 
this possibility with the molecular probe 4,4'-Dianilino-1,1'-Binaphthyl-5,5'-Disulfonic Acid 
(bis-ANS). The spectral properties and the quantum yield of bis-ANS are highly sensitive to 
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polarity, thus upon binding to hydrophobic surfaces bis-ANS becomes appreciably more 
fluorescent. A unique feature of bis-ANS is its ability to selectively identify different aggregation 
states of Aβ40 through distinct emission spectra (Fig. 3.1c) (22, 37, 38). The emission spectra of 
bis-ANS after isolation and separation of the fibrils from disordered oligomers is shown in Fig. 
3.1c, along with the bis-ANS signal from a freshly dissolved Aβ40 sample prepared without 
incubation or seeding. The emission spectrum of bis-ANS in the spin-X-isolated oligomers (Fig. 
1c, blue) is significantly more blue-shifted than that of the emission spectrum observed from the 
fibril fraction (Fig. B.1). Also in Fig. 3.1c, the bis-ANS fluorescence observed in the presence of 
the freshly dissolved Aβ40 sample (red) is only slightly blue-shifted from that of the spectrum of 
bis-ANS alone (black), indicating limited binding of bis-ANS to monomeric Aβ40 and a 
significant difference in the hydrophobic exposure compared to the freshly dissolved Aβ40 or the 
Aβ40 fibrils.  
In addition to the bis-ANS measurements, dynamic light scattering (DLS) studies 
revealed distinct size distributions of these disordered Aβ oligomers when compared to the 
freshly dissolved Aβ40 sample (Fig. 3.1d and Supplementary Fig. B.2). DLS measured a RH of 
~5.1 nm with a polydispersity of 32.2% for the oligomers isolated by spin-X filtration, whereas 
the RH of the freshly dissolved Aβ40 sample was ~1.4 nm with a polydispersity of 19.0%. To 
complement our optical spectroscopy data, representative electron micrographs and AFM images 
of the amyloid preparations showed oligomeric and fibrillar forms present in the aggregated 
sample of Aβ40 (Fig. 3.1e-f). All AFM images showed the disordered Aβ oligomers exhibit an 
amorphous, spherical morphology (Fig. 3.1e). The oligomers were found present among a dense 
fibrillar network whose bundled, twisted features were apparent in all electron micrographs as 
observed in Fig. 3.1f. Taken together, all biophysical measurements point to the existence of a 
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disordered and soluble Aβ40 oligomer coexisting as a minority population amongst Aβ40 fibrils. 
This finding is very intriguing as it indicates Aβ40 is simultaneously undergoing β-sheet and 
non-β-sheet aggregation pathways. For this reason, we aimed to find distinct structural features 
that contributed to the formation of such an Aβ oligomer. 
 
 
Figure 3.2 RFDR-based 2D 1H/1H chemical shift correlation spectra on solution samples of freshly 
dissolved (red) and aggregated (blue) forms of Aβ40.  
(a) Side-chain to Hα, (b) side-chain, and (c) Hβ-Hα and Hα -Hα regions of the overlaid 2D spectra were 
recorded under 2.7 kHz MAS. The dotted circle highlights the Ser and Gly fingerprints of the aggregated 
Aβ40 sample. Peak assignments are given for the mixed Aβ40 sample. The spectra were acquired with a 
50 ms mixing time at 600 MHz in 100% D2O, 10 mM sodium phosphate buffer, pH 7.4, and 37 °C. Total 
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Aβ40 concentrations for both samples were 462 µM; the estimated oligomer concentration in the 
aggregated sample is 35 ± 12 µM. The acquisition time was 4 days. 
The RFDR-based 2D 1H/1H chemical shift correlation provides site-specific information 
on a minority population of disordered Aβ40 oligomers in a fiber-containing sample. To obtain 
an atomic-level picture of these disordered oligomers, we use a combination of solution- and 
solid-state NMR experiments. RFDR is different from the NOESY experiment in that the 
incorporation of rotor-synchronized π-pulses during the mixing period reintroduces coherent 
homonuclear dipole-dipole interactions (Supplementary Fig. B.3). We first performed RFDR-
based 2D 1H/1H experiments on two types of samples: the unfiltered, aggregated Aβ40 sample 
used in the CD experiments and a control sample of freshly dissolved Aβ40 without fibers made 
primarily of monomeric and low MW species. An overlay of the two 2D RFDR spectra is shown 
in Fig. 3.2. Only a few cross-peaks are observed in the 2D 1H/1H spectrum of the freshly 
dissolved Aβ40 sample (red in Fig. 3.2), probably due to the rapid tumbling of monomeric 
and/or low molecular weight Aβ40. The few cross-peaks that do appear in the spectrum of 
freshly dissolved Aβ40 likely arise from early aggregates, and the presence of peaks appearing 
near 0 ppm in the 1D 1H spectrum suggests that this is indeed the case (Supplementary Fig. B.4). 
Such peaks (near 0 ppm) are commonly observed in the spectra of amyloidogenic peptides, and 
have been shown to occur due to the presence of an oligomeric species in which aliphatic protons 
are solvent protected and thus shifted to the high field region of the 1D 1H spectrum (39, 40). 
However, with the exception of these few cross-peaks, the RFDR-based 2D 1H/1H spectra of 
unaggregated Aβ40 is very sparse, consistent with weak (to negligible) 1H-1H dipolar couplings 
in low MW samples. The RFDR-based 2D 1H/1H experiment therefore acts as an efficient 
spectral filter for intermediate sized oligomers; low MW exhibit few cross-peaks because of 
weak (to negligible) 1H-1H dipolar couplings while the linewidth from very high MW species 
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like amyloid fibers is too large (due to very strong dipolar couplings) to generate a detectable 
signal under the slow MAS speeds used in this study.  
 
 
Figure 3.3 MAS spectra of the filtered disordered Aβ40 oligomer.  
An overlay of the assigned Hα regions from RFDR-based 2D 1H/1H (blue) and 2D 1H/1H TOCSY (red) 
spectra acquired at 298 K with 10 kHz MAS. The filtered oligomer sample was lyophilized and re-
hydrated to double its initial concentration, making for a total Aβ40 of ~35 µM. The RFDR and TOCSY 
based 2D 1H/1H spectra were acquired with mixing times of 50 and 70 ms, respectively, at 600 MHz in 
100% D2O, 10 mM sodium phosphate buffer, pH 7.4. RFDR spectra were acquired at 25 °C under 10 
kHz MAS. Assignments are given for the RFDR-based 2D 1H/1H spectra. The non-uniform sampling 
based data acquisition time was 4 hours. 
In contrast to the sparse spectra obtained from unaggregated Aβ40, the RFDR-based 2D 
1H/1H spectra of the aggregated sample showed multiple cross-peaks consistent with the 
presence of the disordered oligomer suggested by the CD, fluorescence, and AFM experiments 
(Fig. 3.1). The dominant feature of the RFDR-based 2D 1H/1H spectra is a very strong upfield 
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shift of Hα resonances compared to both the expected random coil values and the unaggregated, 
primarily monomeric sample. Upfield shifts typically derive from two primary sources: the 
formation of helical secondary structure and the shielding of the residue from solvent. 
Unfortunately, the spectra in Fig. 3.2 are not sufficient to distinguish between these two sources. 
However, this spectrum was taken under rather extreme conditions of low concentration 
(~35 µM) and high heterogeneity (the oligomers only constitute 7-10% of the entire sample) to 
test the limits of the technique to samples not traditionally considered amenable for NMR. To see 
if additional structural details could be resolved in a more conformationally pure sample, we 
performed the RFDR-based 2D 1H/1H experiment on purified oligomers by removing the fibers 
through Spin-X filtration. We first tested the influence of the MAS rate by increasing it up to 15 
kHz (Supplementary Fig. B.5). The fact that the resolution of 1D 1H spectra does not improve 
with the increasing MAS rate suggests that oligomers are not sedimenting out of solution at the 
speeds used in the experiment, although the selective sedimentation of fibers may play a role in 
enhancing the resolution of the mixed fiber/oligomer sample (30). 
Under 10 kHz MAS, we were able to obtain a well-resolved RFDR-based 2D 1H/1H 
spectrum of the pure oligomer sample (Fig. 3.3).  A majority of peaks assigned in the RFDR-
based 2D 1H/1H spectrum of the unfiltered sample (Fig. 3.2) are identified in the spectrum of the 
filtered oligomer sample as well (Fig. 3.3), suggesting peaks appearing in both samples arise 
from conformationally similar species. Under these conditions, it was possible to perform a 
partial assignment of the resonances using TOCSY experiments under MAS (Figs. 3.3, red 
spectrum). The lack of complete connectivity hampered the complete assignment of peaks in 
RFDR-based 2D 1H/1H spectra. Accordingly, the assignments of a partially folded structure of 
Aβ40 guided unambiguous assignment of 2D 1H/1H NMR spectra (14). While the lack of 
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connectivity is unavoidable given these constraints, the results suggest a spectrum that, while 
unusual for either a well-folded or unstructured protein, is consistent with results obtained from 
other biophysical experiments shown in Fig. 3.1. At the atomic level, the RFDR-based 2D 1H/1H 
spectrum contains inter-residue cross-peaks between the aliphatic and alpha protons of K28-G29, 
S26-N27, H13-G38, and S8-E11. These inter-residue contacts are observed for both 20 and 50 
ms RFDR mixing times (Supplementary Fig. B.6), indicating the interaction of these residues are 
prominent features for the oligomer’s structure. Moreover, the Ser and Gly fingerprints are 
observed only for the disordered oligomer species (circled cross-peaks in Fig. 3.2), suggesting 
the involvement of these residues in the oligomer formation and stabilization. More generally, 
though there are very strong up-field shifts for the resonances that usually suggest helix 
formation, no medium range αN (i, i+3/i+4) connectivity was found indicative of an α- or 310- 
helical conformation. Rather, the strong upfield shift appears to be the result of the 
oligomerization of peptide and the consequent shielding of the residues from solvent. Taken 
together, this finding suggests a dynamic and disordered structure with a high degree of turns and 
twists but without a well-defined secondary structure.  
We do not rule out the possibility that highly mobile regions of the fibril may contribute 
in part to the RFDR spectrum recorded on the mixed fibril-oligomer sample. The serine and 
glycine fingerprints highlighted in Fig. 3.2 are not found in the RFDR spectra of the filtered 
oligomer nor are they found in the freshly dissolved samples of Aβ40. Nevertheless, a majority 
of the cross-peaks assigned in the RFDR spectra of the filtered oligomer are the same as those 
assigned in the unfiltered Aβ40 sample. Given that any highly mobile residue from the Aβ fibril 
would largely maintain the fibril’s correlation time, it is more than likely that cross-peaks 
observed in the RFDR spectrum of the unfiltered sample derive from the disordered Aβ40 
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oligomer as MAS experiments performed on the filtered oligomer (Fig. 3.3 and Supplemental 
Fig. B.5). Isolation of the oligomer, although helpful in improving the resolution (compare Fig. 
3.2 and Fig. 3.3), is not strictly necessary. 
 
 
Figure 3.4 The disordered Aβ40 oligomer grows in size while maintaining its morphology.  
(a) DLS experiments at 19 days demonstrate that the disordered oligomer not only remains disordered, 
but also grows in size as well with a distribution of hydrodynamic radii at 8.6 nm and 65.3 nm and 
polydispersity of 14.9% and 37.8%, respectively. (b) The strong minimum at ~ 200 nm in the CD 
spectrum of the disordered oligomer after 19 days reveals that the oligomer does not progress to a fibrillar 
state. Two-dimensional spectra of the fingerprint region of (c) TOCSY (70 ms mixing) and (d) NOESY 
(250 ms mixing) of the disordered Aβ1–40 oligomers recorded at 4 days (blue) and 19 days (red). The 
filtered oligomer sample was lyophilized and re-hydrated to double its initial concentration, making for a 
total Aβ40 of ~35 µM. After 19 days (red), almost all peaks are broadened beyond detection in both 
TOCSY and NOESY spectra. 
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The disordered Aβ40 oligomer is conformationally stable and grows in size. In light of 
our ability to purify the disordered Aβ oligomer, we were interested in whether the oligomers 
would aggregate into a fibrillar state. CD and DLS measurements confirm that the disordered 
nature of the oligomer is maintained while increasing in size over the course of 19 days (Fig. 
3.4a-b). The CD spectrum of the spin-X-isolated oligomer at 19 days (Fig. 3.4b) shows a 
minimum intensity ca. 198 nm, indicative of random coil structure, and the DLS experiments 
indicate an increase in hydrodynamic radius of the oligomer from ~5.1 nm to ~8.6 nm (Fig 3.4a). 
Solution and MAS NMR experiments further demonstrate that the spin-X-isolated Aβ 
oligomers are conformationally diverse and grow over time, yet maintain their disordered nature. 
The 1D profiles of 1H MAS spectra do not change significantly over a period of 16 days, 
indicating the general fold of the oligomer is preserved. Between 4 and 9 days, the two sharp 
peaks at 1.20 and 1.18 ppm broaden beyond detection, while at the same time the oligomer peak 
at 0.16 ppm undergoes similar line-broadening (Supplementary Fig. B.7). We attribute this line-
broadening to the increasing size of disordered Aβ oligomers. Even after 4 days of aggregation, 
cross-peaks were not observed in 2D NOESY spectra under MAS conditions (Supplementary 
Fig. B.8).   
RFDR reveals details that solution NMR cannot for intermediate size oligomers. Since 
the RFDR pulse sequence (Supplementary Fig. B.3) utilizes the transfer of proton magnetization 
via coherent 1H/1H dipolar couplings and an incoherent cross-relaxation from the NOE to 
generate cross-peaks (34), we would expect the RFDR pulse sequence to be more sensitive to 
larger oligomers than the traditional NOESY experiment utilizing only NOE cross-relaxation. 
Accordingly, cross-peaks were not observed in 2D NOESY spectra obtained under MAS 
conditions and very few peaks were observed under static conditions (Supplementary Fig. B.8), 
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indicating the dipolar interaction among protons dominates the transfer of magnetization 
between nuclei of the disordered Aβ40 oligomer as evidenced by the RFDR spectrum in Fig. 3.3 
(blue).  
 
 
Figure 3.5 Comparison of 1H/15N HSQC spectra of the freshly dissolved (red) and the spin-X-
isolated disordered oligomer (blue) of Aβ40 (after 4 days) recorded from a 900 MHz spectrometer. 
Both experiments were performed in 10 mM phosphate buffer, pH 7.4, and 10% D2O at 25 °C. 
We further tested this observation by comparing the results from the RFDR experiment to 
solution NMR experiments using the time dependent growth of the oligomer from 4 to 19 days 
(Fig. 3.4c-d). Static TOCSY spectra (Fig. 3.4c) over this timeframe showed a severe decrease in 
the number of cross-peaks observed, while NOESY experiments under static conditions yielded 
little to very few cross-peaks at 4 days (Fig. 3.4d) and no cross-peaks were observed for the 
NOESY experiment at 19 days (data not shown). Similarly, 2D 1H/15N heteronuclear single-
quantum correlation (HSQC) experiments performed on the spin-X-isolated oligomer of Aβ40 
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after 4 days (Fig. 3.5) exhibit drastically different HSQC spectra than that observed for a freshly 
dissolved Aβ40 sample (41, 42). Only four peaks are observed in the HSQC spectrum of the 
isolated, disordered Aβ40 oligomer after 4 days of aggregations; these likely coming from highly 
mobile residues and/or mobile side-chains. These results then suggest that molecular motions do 
not average out the 1H/1H dipolar interaction of the oligomer, and therefore the peaks are 
broadened beyond detection in solution NMR experiments. We therefore conclude that while the 
oligomer is observable by traditional solution NMR experiments, only limited information can 
be acquired, in contrast to the high-resolution information obtained from the RFDR-based 2D 
1H/1H MAS solid-state NMR experiment. 
3.3. Conclusions 
 
Figure 3.6 Simultaneously occurring aggregation pathways of Aβ40.  
Early aggregates maintain structural similarity to the stable, disordered Aβ40 oligomers observed at late 
aggregation stages. The early aggregates either (i) solely nucleate the disordered oligomers or (ii) act as a 
single nucleating seed from which the two distinct aggregation pathways bifurcate. 
Using the 1H/1H RFDR technique, we were able to reveal the dynamic and disordered 
structure comprised of turns and twists for the intermediate size (5-10 nm) oligomers. Through 
the implementation of both solution- and solid-state NMR experiments, particularly through the 
1H/1H dipolar couplings recoupled by RFDR, we have characterized high-resolution structural 
properties of a dynamic and disordered Aβ40 oligomer and the development of early amyloid 
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aggregates. Disordered and/or micelle-like structures have been observed for other amyloid-
forming proteins and peptides as well (43–46). In terms of a stable conformation, the oligomers 
studied here resemble, at least biophysically, conformers generated by small molecule amyloid 
inhibitors (such as polyphenols like EGCG (41, 47) or resveratrol (48)); i.e inert Aβ species that 
are large and predominantly unstructured. However, the stable oligomer studied here occurs 
without small molecule perturbations or chemical modifications in the Aβ peptide sequence. 
Furthermore, this disordered oligomer forms simultaneously with the highly ordered and well-
defined structure of the β-sheet fibrils, indicating that a single aggregation pathway is not 
necessarily prevalent for a given preparation of Aβ (Fig. 3.6). Whether the disordered Aβ 
oligomer studied here is cytotoxic remains to be determined; however, the fact that this 
disordered conformation persists to an end-state that is not fibrillar is unexpected in light of the 
concept of nucleated conformational conversion and Aβ40 aggregation pathways in general (49, 
50). 
In a more general sense, our results demonstrate the value of the RFDR-based 2D 1H/1H 
experiment in obtaining high-resolution information on supramolecular assemblies not easily 
amenable to analysis by other biophysical techniques, including solution NMR and other solid-
state NMR experiments. Specifically, most of the high-resolution data so far on amyloid 
oligomers and fibers has come from solid-state NMR experiments. These experiments have been 
invaluable in advancing our understanding of amyloid and other supramolecular assemblies. 
However, solid-state NMR experiments are inherently insensitive and require frozen or 
lyophilized samples that must also be isotopically labeled, often in a site-specific fashion that 
requires chemical synthesis rather than recombinant expression. Importantly, the 1H/1H RFDR 
experiment can be run on liquid samples using proton detection. For this reason, it is a highly 
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sensitive when compared to traditional solid-state NMR experiments and, at the same time, is 
able to access a molecular size range inaccessible to solution NMR experiments. Since it is run 
under solution conditions that allow dynamic averaging and very large insoluble aggregate 
species are spectrally filtered out by the procedure, it is also very tolerant to both conformational 
heterogeneity and heterogeneous oligomer size distributions. This is shown by Fig. 3.2, which 
shows the signal of the oligomer can be resolved without purification even though the oligomer 
comprises only ~7% of the total sample. Finally, since the experiment does not require isotopic 
labeling, it does not need recombinant protein expression. All of these characteristics make it 
ideal for medically relevant samples that have been difficult to characterize, such as amyloid 
oligomers directly derived from the brain, which in some cases have shown intriguingly different 
properties than the corresponding recombinant or synthetic Aβ peptide (13, 51–54). 
3.4. Methods 
3.4.1. Peptide Synthesis. 
Aβ40 was synthesized manually by solid-phase Fmoc-based chemistry using the 
dimethoxybenzyl-protected (dmn) dipeptide, Fmoc-Val-(Dmb)-Gly-OH at positions 36 and 37 
for the purpose of preventing aggregation during synthesis. The peptide was cleaved from the 
resin using 92.5% trifluoroacetic acid (TFA), 2.5% H2O, 2.5% ethanedithiol, and 2.5% anisole. 
The crude peptide was dissolved in 20% acetic acid (v/v) and purified by reverse-phase HPLC 
using a Waters semipreparative C18 column equilibrate in 0.1% TFA. The peptide was eluted 
with a linear gradient of 0-80% acetonitrile at a flow rate of 10 ml/min. Proper synthesis and 
purification were validated using matrix-assisted laser desorption ionization mass spectrometry, 
which gave a value corresponding to the correct mass 4329.9 Da. 
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3.4.2. Sample Preparation.  
To remove preformed aggregates, the purified peptide was dissolved in 1% ammonium 
hydroxide (v/v) at a concentration of 1 mg/ml followed by removal of the solvent by 
lyophilization for 24 hours in aliquots of either 0.1 or 0.3 mg. The aliqouted peptide was then 
stored at -20 ᴼC and only used once.  
3.4.3. Preparation of Aggregated Aβ40 Sample:  
For preparation of Aβ40 aggregated sample containing a mixture of fibers and disordered 
oligomers, 0.1 or 0.3 mg of the lyophilized peptide was solubilized in a 10 mM sodium 
phosphate buffer (pH 7.4) solution at a concentration of 1 mg/ml (231 µM) and incubated for 48 
hours at 37 ᴼC under agitation at 1000 rpm. This aggregated Aβ40 sample was then used to seed 
5% of the total concentration of freshly dissolved Aβ40 in the same buffer conditions at a total 
Aβ40 concentration of 1 mg/ml. The seeded Aβ40 sample was incubated for 48 hours at 37 ᴼC 
under agitation at 1000 rpm to form a sample containing a minority of Aβ40 oligomers (17.0 ± 
6.0 µM or ~10% of the total peptide concentration) amongst a much larger population of Aβ40 
fibrils. Concentrations were determined by the Thermo-Scientific BCA protein assay kit from 3 
independent samples.  
3.4.4. Isolation of Disordered Oligomers:  
Upon completion of preparing the seeded Aβ40 aggregates (i.e. at the end of the 4 day 
incubation period), disordered oligomers were isolated using a Spin-X microcentrifuge spin 
column (Corning Inc.), containing a 0.22 µm cellulose acetate filter. The filtrate contained the 
isolated Aβ40 disordered oligomer (the 4-day old oligomer) and the Aβ40 fibrils were retained in 
the retentate. Due to the concentrations of the disordered oligomers being very low for NMR 
measurements, these samples could be lyophilized and rehydrated at double their concentration 
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(quantified above). This had no effect on the solution characteristics of the sample, namely its 
size, morphology, or secondary structure as verified by CD and DLS. 
3.4.5. Monomer preparation (i.e., Freshly Dissolved Aβ40):  
Preparation of Aβ40 monomer sample was performed as described previously.14 Briefly, 
0.1 mg of the lyophilized peptide was first dissolved in 10 µl of 1 mM NaOH and sonicated until 
the peptide was solubilized. The peptide solution was then hydrated in H2O (or 100% D2O for 
MAS NMR measurements), buffered in 10 mM sodium phosphate (pH 7.4) and diluted to 76 µM 
(0.1 mg in 300 µl).  
3.4.6. NMR Spectroscopy.  
All NMR data was processed using TopSpin 2.1 (Bruker). 1D data were analyzed using 
TopSpin 2.1 and 2D data were analyzed using SPARKY. In all NMR spectra, the 1H peak from 
H2O was used as a chemical shift reference by setting its frequency at 4.7 ppm. 
MAS NMR experiments were performed at 298 K or 310 K on an Agilent/Varian 
VNMRS 600 MHz solid-state NMR spectrometer using a 4 mm 1H/X double-resonance 
Nanoprobe. The spectrometer was operated with a deuterium field lock and a MAS spinning 
speed of 2.7 kHz. The proton carrier frequency was set to the resonance frequency of water for 
all experiments and H2O signal was suppressed using a 10 Hz saturation RF pulse for 1 s at the 
beginning of NOESY or RFDR-based 2D 1H/1H experiments. The radio frequency field strength 
used for the 90° and 180° pulses was 61 kHz. The NOESY and RFDR-based 2D 1H/1H spectra 
were recorded using 1100 scans, 200 t1 increments, 6252 t2 complex points and a spectral width 
of 11 ppm in both frequency dimensions. The experimental data sets were zero-filled in both t1 
and t2 dimensions to form a 2048 x 4096 data matrix. Phase shifted sine bell multiplication was 
applied to both dimensions prior to Fourier transformation. Since the maximum MAS rate 
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possible with the Agilent Nanprobe is 2.7 kHz, to achieve higher MAS rates while maintaining 
the utility of deuterium locking and pulse-field gradients, we used a Bruker complete multi-phase 
(CMP) probe on a Bruker 600 MHz Avance III NMR spectrometer. 1D 1H NMR spectra were 
acquired for MAS speeds from 5 to 15 kHz (Supplementary Figure 5). RFDR-based 2D 1H/1H 
experiments were performed under 10 kHz MAS with mixings times of 20 and 50 ms and using 
non-uniformly sampled (NUS), interleaved datasets. NUS datasets, where each dataset is split 
into its 2 component datasets using the Split program, were processed separately with the 
standard ‘xfb’ command, which regenerates the missing points and transforms the datasets. 
Assignment of proton resonances was done using SPARKY with published assignments 
for Aβ40 as a guide. 1D 1H MAS experiments were recorded with 20000 scans, 16 dummy 
scans, a spectral width of 12 ppm, and an acquisition time of 0.5 s. The proton carrier frequency 
was set at water resonance for all experiments and H2O resonance was suppressed using a 50 Hz 
RF pulse for 1.5 s.  
Solution NMR spectroscopy was performed on the filtered oligomer. Data were acquired 
on a 900 MHz Bruker NMR Spectrometer equipped with a cryogenic triple-resonance pulse-field 
gradient probe. 1D and 2D NMR spectra were collected at either 298 K or 310 K. NOESY 
spectra were acquired with a spectral width of 12 ppm in both dimensions; with 400 (ω1) and 
2048 (ω2) complex points using a 1.5 s recycle delay. The NOESY experiments were acquired 
with two different mixing times: 250 and 600 ms. Solvent suppression was done using gradient 
pulses centered at 1H resonance frequency of water. The same parameters were used for TOCSY 
experiments; however, mixing times of 70 and 100 ms were used. The experimental data sets 
were zero-filled to form a 2048 x 4096 data matrix and a phase-shifted sine bell multiplication 
was applied to both dimensions prior to Fourier transformation. 15N-labeled Aβ40 was purchased 
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from rPeptide (Athens, GA, U.S.A.) and used for HSQC experiments. The exact same sample 
preparation protocols detailed above were used for 15N-labeled Aβ40 samples. Each spectrum 
was obtained from 128 t1 experiments, 92 scans (for the spin-X-isolated Aβ40 oligomer) and 1 s 
recycle delay.  
3.4.7. Circular Dichroism (CD).  
CD measurements were performed on JASCO J-715 Spectropolarimeter using a 0.1 cm 
path length cell. Isolated oligomer and fibril samples of Aβ40 were prepared as described above. 
Molar CD per residue values were calculated using ε = θobsd/(3298lcn), where θobsd is the 
observed ellipticity measured in millidegrees, c is the molar concentration, l is the cell path 
length in centimeters, and n is the number of residues in the peptide.   
3.4.8. bis-ANS and Thioflavin T Fluorescence Assays.   
Aβ40 fibril formation was measured by increased fluorescence emission upon binding of 
amyloid fibers to the commonly used amyloid-specific dye, thioflavin T (ThT). Aβ40 oligomer 
and fibril formation were also measured by fluorescence emission spectra of the less specific 
dye, 4,4'-Dianilino-1,1'-Binaphthyl-5,5'-Disulfonic Acid (bis-ANS); purchased from Santa Cruz 
Biotechnology, Inc. bis-ANS exhibits limited fluorescence in water; however, becomes 
considerably fluorescent upon binding hydrophobic surfaces. Isolated oligomeric and fibrillar 
Aβ40 species were prepared as described above. The retentate containing Aβ40 fibrils was 
dissolved in 200 µL of 10 mM sodium phosphate buffer, pH 7.4, of which 90 µL was then 
aliquoted into microcentrifuge tubes. Similarly, the filtrate containing the Aβ40 oligomers was 
aliquoted into 90 µL quantities as well. Either ThT or bis-ANS fluorescent dye was then added to 
a peptide aliquot at a concentration of 10 µM and fluorescence emission was measured on a 
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Horiba FluoroMax 4 spectrofluorometer. An excitation wavelength of 446 nm and 350 nm was 
used for ThT and bis-ANS, respectively. 
3.4.9. Atomic Force Microscopy (AFM).  
An aggregated Aβ40 sample prepared as described above was deposited onto freshly 
cleaved mica and incubated for twenty minutes at room temperature. The surfaces was rinsed 
with nanopure water and dried under nitrogen flow. Dry imaging was carried out in tapping 
mode using a Nanoscope III atomic force microscopy (AFM) and JZ Scanner (Veeco) with 
VistaProbes T300R (NanoScience, AZ; nominal radius 10 nm, force constant 40 N/m, resonance 
frequency 300 kHz). The AFM was calibrated with a 100 nm x 100 nm standard (2D-100, 
NANOSENSORS, Switzerland). After calibration, the percent error was -0.6%. Random 
locations on the sample were selected for imaging. Particles were detected and height 
measurements were made using SPIP 6.0.13 software (NanoScience Instruments). 
3.4.10. Dynamic Light Scattering (DLS).   
Light scattering experiments were performed on Aβ40 samples prepared as described 
using a DynaPro Nanostar instrument from Wyatt Technology (Santa Barbara, CA). Light 
scattering was measured at 90°. The intensity correlation function and the distribution of the 
hydrodynamic radii (RH) of the particles contributing to the scattering were determined using 
DYNAMICS software (Wyatt Technology). 
3.4.11. Transmission Electron Microscopy (TEM). 
Samples for negative stain TEM analysis were deposited on continuous carbon films on 
copper rhodium 100 mesh grids (Electron Microscopy Sciences, EMS Hatfield PA.). Prior to 
adding samples, the grids were charged using a glow discharger for 15 s at 30 mA negative 
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discharge. Fibrillar and oligomer sample solutions at 1 mg/ml were adsorbed to the grids for 2 
minutes prior to rinsing with two 10 µL drops of water for 10 s. Samples were blotted using No. 
2 Whatman filter paper. Samples for TEM were then stained with a 10 µL drop of freshly filtered 
2% uranyl acetate (EMS) for 15s before blotting excess stain. Samples were analysed using a 
Philips CM-100 microscope operating at 80 kV. 
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Chapter 4: Elucidating the Mechanism of Amyloid-β 
Aggregation Using Fast-Acquisition NMR Methods 
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4.1 Introduction 
Studying the fibrillation process of amyloid proteins has long been and still is of great 
importance, both for the development of reliable and early-stage diagnostic methods and for the 
identification of compounds that interfere with the protein misfolding process. The extreme 
stability of amyloid fibers and the long time scale for aggregation indicates that amyloid 
formation is a thermodynamically favorable process with a high activation barrier under kinetic 
control (1). Amyloid fiber formation is often modeled as a nucleation dependent process, (2) 
kinetically similar to one-dimensional crystal growth (3,4). In its most basic form, the first steps 
of the kinetic model consist of sequential, reversible addition of monomeric proteins to form 
energetically unfavorable and, therefore, rare intermediates. In the classical nucleation dependent 
polymerization model, (2)  this process continues until a nucleus is created from which further 
aggregation is favorable. Upon formation of nuclei, aggregation propagates rapidly and, 
ostensibly, leads to cellular dysfunction.  
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Because the intermediate species are transient and difficult to observe, the experimental 
evidence for the nucleation dependent polymerization model for amyloid formation largely rests 
on kinetic modeling rather than direct experimental measurements. However, many kinetic 
models are consistent with the available data, and the simplest model that fits the limited data 
available is not necessarily the most relevant. The task is made more difficult as typically only 
the total fiber concentration is measured through the amyloid specific dye Thioflavin T and the 
concentrations of other species are interpolated from the model. A similar result was obtained by 
following the dissolution of radiolabeled monomers from the ends of unlabeled fibers (5). The 
resulting kinetics were interpreted as a two-stage binding mechanism in which the fast reversible 
association of monomeric Aβ to fibers (“docking”) is followed by a second, slower step, which 
was interpreted as a conformational transition of the incoming monomer on the fiber surface that 
results in essentially irreversible binding (“locking”) (6,7). The dock-lock mechanism of fiber 
elongation therefore consists of two steps: fast non-specific reversible association with the fiber 
surface in a non-native conformation followed by the slower adoption of the native fiber 
conformation once bound (5,7). Direct measurements of the elongation rate from preexisting 
fibers by fluorescence microscopy have revealed a more complicated picture in which fiber 
formation proceeds in a stop-and-go manner with bursts of fast elongation often followed by 
quiescent periods in which fiber elongation proceeds slowly or not at all (8-11). The stop-and-go 
manner of fiber elongation suggests the peptide has docked but not locked, blocking the fiber end 
and preventing incoming monomeric peptide from attaching to that fiber (7).     
Despite these advances, a molecular understanding of the docking and locking process has 
been absent. Computationally, the dock-lock hypothesis has been explored by molecular 
dynamics which suggests a rugged landscape for fiber elongation (12-16) with both productive 
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and non-productive binding modes (17). A structural understanding of this process at the atomic 
level has proven very difficult to achieve experimentally as the growing end of the fiber 
comprises only a small fraction of the total sample and the large size of the fibers make them 
difficult to observe with most biophysical techniques. Here, we use solution NMR of an Aβ40 
sample seeded with amyloid fibers to indirectly observe the docked state, which is not directly 
observable by solution NMR through the influence of the exchange-averaged NMR signal of the 
directly observable Aβ40 free in solution. We find that docking primarily proceeds through two 
stretches of residues in the central and C-terminal regions of the peptide, F19-K28 and L34-G37, 
with the highest degree of interaction focused on a small stretch of residues (F19-E22) that have 
been implicated in familial AD by mutational analysis as strongly influencing the fiber 
elongation rate (5,18). 
4.2 Results 
The SOFAST-HMQC experiment offers a unique ability to monitor Aβ aggregation at 
atomic resolution without the time constraints typical of most 2D NMR experiments, allowing 
the kinetic processes of fibril assembly to be monitored with residue specificity.  As a control, 
we first measured the rate of monomer loss in unseeded solutions of Aβ40 through sequentially 
acquired 1H-15N SOFAST-HMQC experiments. In the absence of a fibril seed, the signal 
remained invariant over 15 hours, without substantial changes in either intensity (Fig. 4.1, black 
circles) or changes in chemical shift  in this time period (Fig. C.1). The absence of any 
significant changes indicates that freshly dissolved Aβ40 is, if not necessarily entirely 
monomeric in nature, at least conformationally stable on the time-scale of our experiments under 
these conditions and does not form new oligomers or otherwise aggregate to any detectable 
extent in the absence of fibers (19,20).  
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Figure 4.1 Aggregation of Aβ40 as monitored by real-time 1H-15N SOFAST HMQC.  
Each point represents the total intensity of all monomer peaks with the peak center adjusted for each time-
point. The sample without fiber present was fit to a line. The seeded experiments at 10° C and 25 °C were 
fit to double- and single- exponential curves, respectively. The two observable phases at 10 °C indicate 
two kinetically distinct processes. The grey bar indicates the time-scale in which the docking mechanism 
is dominant. 
 To initiate fiber growth in the sample, we seeded the reaction with 5 mol % 
preformed fibers prepared by incubating a 150 µM Aβ40 sample for 48 hours at 37 °C with 
constant agitation. The final result of this process is short, straight and largely unbranched 
amyloid fibers (Fig. 4.2B). Seeding the aggregation reaction with these fibers causes complex 
time-dependent changes in the spectra obtained from real-time 2D NMR experiments (Fig. 
4.2A), suggesting an underlying dynamic process that is not present in the absence of fibers. The 
most prominent difference between the seeded and unseeded samples is a strong decrease in 
signal over time in the seeded samples (Fig. 4.1, blue and red lines). The most straightforward 
explanation is the signal loss simply represents the loss of monomeric peptide to a species that is 
invisible to NMR; however, this explanation is contradicted by the data. In general, large 
aggregates give rise to very broad signals that are undetectable in solution NMR unless a 
substantial amount of local conformational flexibility exists that averages out the dipole-dipole 
interactions and chemical shift anisotropy for particular residues (21). This flexibility does not 
exist in the fiber conformation as all residues are locked into a conformation that is tightly picked 
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against the fiber body except for nine residues at the N-terminus. If the peptide immediately 
adopts this rigid conformation after binding, the signal should decrease uniformly without 
broadening as only the signal from the remaining unbound peptide can be observed. Instead of a 
uniform decrease, there is a distinct variation along the peptide backbone at 10°C, which is 
initially slight but increases substantially as time progresses (Fig. 4.2A and C.2). This non-
uniform intensity decrease can also be seen at 25°C even at the initial time point (Fig. C.3). The 
non-uniform decrease argues against such a single step binding mechanism, consistent with both 
previous kinetic experiments on fiber elongation in immobilized samples and the existence of 
two distinct kinetic phases in our real-time 2D NMR experiments at 10 °C (Fig. 4.1, blue line).  
 
Figure 4.2 Real-time 2D NMR demonstrates residue-specificity of seeded Aβ40 aggregation.  
(A) Time dependent variation of the SOFAST-HMQC signal of 80 µM freshly dissolved Aβ40 with 5 
mol% fiber seeds along the peptide backbone during the fiber elongation reaction at 10 °C. Points 
represent the signal intensity of the peak maxima relative to the signal intensity in the absence of fiber 
seeds. The first time point (0 hr, top) represents the first spectra acquired immediately after the addition of 
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the fiber seeds. (B) Electron micrograph of a 150 µM Aβ40 sample incubated for 24 hours at 37°C with 
constant agitation. The amyloid fibers from this experiment were used as preformed amyloid seeds for the 
time dependent studies on aggregation. (C) Time traces for representative residues in the N-terminal, 
central hydrophobic, and C-terminal regions. Time trace for all residues can be found in the supporting 
information as Figs S2 (10 °C) and S3 (25 °C).  
4.2.1 Soluble Aβ40 Makes Transient Non-Native Contacts with the Fiber Surface  
Consideration of the real-time NMR experiments points to the Aβ monomer initially in 
dynamic association with the amyloid fiber. There are only a few contacts of the monomer on the 
fiber surface, resulting in weak reversible association on the millisecond timescale (18). Outside 
of the residues directly in contact with the fiber surface (Fig. 4.3, black cirlces), the remainder of 
the peptide in this model is conformationally flexible (20,22) and, therefore, resembles the 
largely unstructured, unbound peptide (23,24). In this tethered model (Fig. 4.3), the influence of 
the fiber on the spectra is most probably manifested indirectly through exchange processes 
between the unbound and bound forms. Depending on the timescale of exchange and frequency 
difference between the bound and unbound states, the peaks in HSQC spectra will either broaden 
due to intermediate exchange (Fig. 4.3B) or the peak position will shift due fast exchange (Fig. 
4.e3A), with approximate exchange lifetimes τex of ~1-10 ms or 1 µs-1 ms, respectively.   
Using this model, it is possible to qualitatively explain the time evolution seen in the 
HSQC spectra. The macroscopic rate constants kon and koff  are dependent on both the 
microscopic rate constants and the concentrations of the soluble peptide and the concentration of 
free fibril ends (fiber ends that are not blocked by a peptide bound in a non-native conformation 
that prevents further extension, i.e. docked but not locked in amyloid terminology). 
Unfortunately, the chemical shifts of the bound states (δbound) cannot be observed for most 
residues and are therefore unknown. The concentration of free fibril ends is also difficult to 
determine directly; however, a qualitative interpretation can be made using the tethered model 
described above. Since all the bound peptide in the fibril seed itself has presumably reached 
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equilibrium, the initial, nearly uniform, intensity decrease and chemical shift perturbation 
observed immediately after the addition of the fiber at 10°C largely represents the initial binding 
to the free fiber.(Fig. 4.3B). After the initial binding to the available fiber free ends, the system is 
now in equilibrium between the unbound peptide and docked peptide bound in a non-fibrillar 
conformation that prevents further extension of the fiber. No time-dependent changes are 
observed for the first 15 residues beyond the fast initial change. This is strong evidence that the 
N-terminal residues are not part of the non-fibrillar, docked binding state and do not make 
contact with the fiber. Time-dependent changes in the spectra are observed for the central 
residues from to K16 to K28. The time-dependence is partially a result of the locking step, which 
occurs due to irreversible binding to the fiber and a gradual shift towards a lower free monomer 
concentration and, consequently, a lower kon and exchange rate. As a result, the exchange 
dynamics shift from the fast to the intermediate exchange regime giving rise to line broadening. 
This is most evident for a stretch of residues from F19-E22 (Fig. 4.2A and C.2).  If the 
assumption of similar kon values for different binding modes is made, these residues will have the 
lowest koff values and, therefore, correspond to the most likely points of contact in the tethered 
model. A similar stretch of residues with a somewhat lesser degree of broadening over time can 
also be seen in the neighboring stretch of residues D23-N27 (Fig. 4.2A). The C-terminus from 
G29-V40 is primarily defined by several residues (G29, I30, I31, M35, G38) whose signal is not 
broadened and remain in fast exchange throughout the experiment with the implication that these 
residues are not in contact with the surface in the bound state conformational ensemble. Within 
the C-terminal region, however, there are other residues such as G33, V36, and G37 that do show 
a substantial degree of broadening at longer time points. The sharpness of the effect suggests the 
contacts in any bound state are limited to only a very small set of neighboring residues. Overall, 
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the data suggest the docked state conformational ensemble is primarily centered in K16-N27 
with only transient contacts outside this range.  
 
Figure 4.3 Cartoon model showing possible modes of interaction of soluble Aβ40 with Aβ40  fibers 
and the effect of the interaction on the NMR spectra.  
(A) Weak association from the transient contact of a few residues with the fiber surface. Fast exchange is 
expected in this case with chemical shift perturbations at the contacting sites. Note that the peptide can 
potentially dock to either the growing ends (right) or sides (left) of the fiber. (B) Stronger association with 
slower on/off rates. Intermediate or slow exchange is expected with the signal decreasing for the 
contacting residues. Outside the contacting residues, the chain is either freely rotating or making transient 
contacts with the fiber. (C) Once bound (“docking”) the peptide adopts the fiber conformation in a 
separate step (“locking”).  No signal can be detected from the locked state directly due to the rigid nature 
of the fiber.  
The time series at 25 °C replicates most of the features of the 10 °C sample with the 
complication that the apparent locking phase is much faster than observed at 10 °C and, as a 
result, the overall signal decreases much more rapidly. The docking and locking stages are no 
longer as kinetically distinct at 25 °C and the loss of peptide to irreversible binding can be seen 
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more prominently early on in the time series (Fig. C.3). Nevertheless, the key features of the 10 
°C time series are replicated at 25 °C. 
 
Figure 4.4 New peaks arising in HSQC spectra suggest slow exchange process in seeded Aβ40 
aggregation.  
(A) C-terminal residues in apparent slow exchange with the fiber surface.  (B) Time evolution of the 
monomer (red) and apparent exchange peaks (blue) for the residues shown in (A) at 10 °C. 
 
4.2.2 2D Real-Time NMR Reveals a Slow Exchange Process Occurring between Aβ40 
Monomers and Fibers Linked to Dynamic Contacts at the C-terminus 
Intriguingly, a new set of peaks reproducibly appears in the later stages of the time series 
at 10 °C. These peaks are not apparent in the samples incubated without fiber seeds indicating 
their production is dependent on, or at least catalyzed by, the fiber surface. Three of the new 
peaks could be assigned to glycine residues 25, 33, and 37 without 3D assignment as the buildup 
of these peaks nearly exactly matches the decrease in intensity of peaks of corresponding to the 
unbound form of these residues (Fig. 4.4 and Fig C.4); a strong indication these peaks are in slow 
exchange with each other. Over longer time periods, such slow exchange processes are gradually 
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observed for other residues as well (Fig. C.5). No new peaks are observed at 25 °C, likely due to 
an increase in the exchange rate at higher temperature. Given the density in other regions of the 
spectrum, it is difficult to correlate the appearance of new peaks to existing peaks in the unbound 
spectra using only the SOFAST-HMQC experiments. Nonetheless, some of the new peaks could 
be assigned from 3D HNCA and HNCACB experiments. Interestingly, the new peaks that are 
assigned are those near the C-terminus and, to a lesser extent the N-terminus, with none of the 
peaks from the central hydrophobic region appearing in the spectrum (Fig. C.6). 
 Because the peaks are in slow exchange, the new peaks must be derived from a 
species that can be directly detected by NMR. However, they cannot be the result of simple 
aggregation from the monomeric state, as such peaks are not detected in the absence of fibers. 
The new peaks could, therefore, result either from the formation of small soluble oligomers 
whose formation is catalyzed by the presence of fibers or by residues that have enough local 
flexibility in the fiber bound state to be directly detectable by NMR. To distinguish between 
these possibilities, we performed pulse field gradient NMR on the sample to characterize the size 
of the NMR detectable species as a function of time. No difference existed between the samples 
with or without fibers and no change in the hydrodynamic radius could be detected over time 
(Fig. C.7). To further establish that the changes seen in the NMR spectra originate from the 
monomer-fiber equilibria, we repeated real-time HSQC acquisition with intermittent sonication 
of the sample for 2 minutes after every 90 minutes of incubation. Sonication is expected to 
mechanically fragment unstable long fibers generating new fiber ends in the process, while 
leaving smaller oligomers less affected (25). The result of the sonication experiment is an 
acceleration of the time-dependent changes seen in the static samples (Fig. C.8).   
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  Based on these results, the appearance of new peaks can be ascribed to fibril 
bound states. While being able to resolve peaks of an Aβ40 monomer bound to its amyloid form 
is unexpected, it is not unprecedented, as highly mobile residues have been directly observed for 
β2-microglubin amyloid fibers in solution NMR (21,26,27). In this case, highly flexible residues 
at the N-terminus could be detected throughout the length of the fiber, despite the fiber’s very 
large molecular weight. More generally, the flexible regions of a number of large biomolecular 
systems, including multidomain enzymes, molecular chaperones, and intact ribosomes, have 
been characterized by solution-state NMR spectroscopy. Although the size of such species can 
greatly exceed the usual limits for solution-state NMR methods, the motional narrowing 
resulting from local mobility can be sufficient to average almost completely the anisotropic 
interactions that normally dominate the transverse relaxation rates. Resonances from such states 
may then have linewidths comparable to those of free peptides in solution. 
 The new peaks must arise from residues with high flexibility in the bound state 
but with chemical shifts significantly different than the unbound peptide. Since the unbound 
peptide is predominantly unstructured, this difference must result from transient contacts at those 
sites with the fiber surface. The appearance of the new peaks is consistent with a two-site 
tethered state model with slow exchange of the entire peptide off the fiber surface and fast on/off 
contacts at another site. The chemical shifts of the new peaks are the time-averaged values of the 
fast on/off contacts.  In this model, the central hydrophobic self-recognition sequence binds the 
fiber relatively tightly while the termini remain dynamic, making only transient contacts with the 
fiber surface. This result is consistent with the new peaks being only found at the dynamic N and 
C-termini and not from the more tightly bound residues in the center of the peptide (Fig C.6).  
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4.2.3 Longitudinal Relaxation Rates Support a Two-Site Binding Model   
The effect of the fiber seed on the relaxation rate provides an alternative method of 
confirming the existence of transient fiber bound states. In the absence of fiber seeds, Aβ40 has a 
near uniform longitudinal relaxation rate (R1) of 1.89 ± 0.2 s-1 across the length of the peptide 
(Fig. 4.5) (19). For a molecule tumbling freely in solution, the longitudinal relaxation rate is 
correlated with the rotational correlation time of the molecule scaled by the internal motion 
occurring at each residue. The absence of a significant variation in R1 values throughout the 
peptide sequence indicates the internal dynamics is largely similar throughout the peptide on the 
ps-ns time-scale, consistent with the rapid conformational interconversion typical of a largely 
unstructured peptide without a single well-defined tertiary or secondary structure. 
The addition of a fiber seed causes a dramatic change in the R1 profile. The relaxation 
rates are no longer uniform, but instead show clear clusters of residues with significantly higher 
than average R1 values that are at least twice that of the remaining residues (Fig. 4.5). The 
enhanced R1 relaxation rates after the addition of fiber seeds is unusual, as it would seem to 
imply significantly enhanced internal motion in the bound state. However, this is based on the 
assumption that the overall molecular tumbling is isotropic, which is untrue for molecules bound 
to amyloid fibers. Because the fibers have a high degree of diamagnetic anisotropy, they 
spontaneously align in the spectrometer along the direction of the magnetic field (28,29). 
Transient contacts with the fiber therefore impart a small degree of alignment to the monomeric 
peptide. The enhanced relaxation rate reflects the effect of increase in dipolar interactions due to 
this small amount of alignment, (30) which average to zero under isotropic tumbling.  
The R1 profile closely matches the pattern of residues with faster than average intensity 
decays in the NMR time course experiments (Fig. $.2A). The most prominent cluster with 
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enhanced R1 values is a four-residue stretch (F20, A21, D22, and E23) in the central region of 
the peptide immediately adjacent to another stretch (V24, G25, S26, and K28- the resonance for 
N27 could not be detected) also exhibiting enhanced relaxation values. Beyond the central 
region, another cluster of residues near the C-terminus (L34, M35, V36, and G37) also shows 
enhanced relaxation. Overall, the R1 profile is consistent with the binding modes suggested by 
the analysis of the apparent chemical exchanges rates (Fig. 4.3) and provides independent 
verification of the two-site binding model (central and C-terminus) suggested by these 
experiments.  
 
Figure 4.5 Variation in longitudinal relaxation rates in the presence and absence of amyloid fibers. 
Fiber seeds were added to a concentration of 5 mol % of the Aβ40 monomer.  
4.2.4 Residual Dipolar Coupling Analysis Suggests Aβ40 Can Partly Bind Perpendicular 
to the Fiber Axis in a Non-Native Conformation 
All of the experiments above provide information on the residues in apparent contact 
with the fiber in the bound state. The spontaneous alignment of fibers in a magnetic field can be 
exploited further to gain structural information beyond that obtainable from the time dependent 
HSQC experiments. The transient contacts with the fibers should manifest in transferred residual 
dipolar couplings (RDCs), which are in turn tied to the orientation of the amide bond with 
respect to the fiber axis (28,29).  In theory, an exact orientation can be defined for each residue 
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with measurable RDCs. In practice, however, this requires an exact knowledge of the bound state 
structure, which is unobtainable for the system being studied here (31). A qualitative analysis of 
the measured RDC values is possible; however, using only the sign of the RDC to assign the 
approximate orientation of the amide bond. The gyromagnetic ratio of 15N is negative and 
therefore a negative RDC is expected if the amide bond is oriented parallel to the fiber axis along 
the beta sheets in the magnetic field, while a positive RDC is expected if the amide bond is 
oriented perpendicular to the fiber axis (28,29). For the residues within the β-sheet regions that 
make up the fiber core (K16-A21 and A30-M35) (32), the presence of a significantly non-zero 
positive RDC therefore implies a non-fibrillar conformation. The majority of the RDCs that 
could be measured are in fact positive.  Significantly, non-zero positive RDCs (DNH> 0.5 Hz) 
could be detected for a stretch of residues from K28-I31 (Fig. 4.6) which are located near the 
loop region in the fiber conformation. The residues in this loop region are expected to have 
fluctuating conformations with some conformations in the ensemble oriented perpendicular to 
the fiber axis. Positive RDCs are, therefore, consistent, but not necessarily indicative of a bound 
state that resembles the fiber conformation. Yet, significantly non-zero RDCs are also found for 
F19 and L34, which are well within the fiber core (fig. 6). Only V24 that is located within the 
loop outside the fiber core has a significantly negative RDC value (Fig. 4.6), although smaller 
negative RDCs can be seen at the C-terminus from G38-V40. While the RDCs cannot be 
interpreted as evidence for a particular structure, they do suggest that the ensemble of bound 
states contains a significant fraction of states that do not resemble the fiber conformation (Fig. 
4.3).  
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Figure 4.6 Residual dipolar couplings induced by the addition of amyloid fibers, which 
spontaneously align parallel to the magnetic field.  
A positive dipolar coupling indicates an orientation of the N-H bond vector perpendicular to the fiber axis 
and a negative dipolar coupling indicates a parallel orientation. 
4.3 Discussion 
The most detailed examination of the binding of soluble Aβ to a fiber-like species at the 
molecular level to date was done by Fawzi et al, who used saturation transfer experiments to 
obtain quantitative estimates of binding to amyloid protofibers at the residue level (20,22,33,34). 
The highest affinity for the protofiber surface was found in two stretches on the monomer (K16–
G25 and K28–G37) that roughly correspond to the residues forming β-sheets in the fiber model 
(20). The differences in site-specific affinity observed in the present can be attributed to the 
distinct structural differences that exist between the protofibers and mature amyloid fibers (35). 
Protofibers are intermediates created when high concentrations (>150 µM) of monomeric Aβ is 
incubated in vitro (20) which differ structurally from mature fibers in their supramolecular 
organization. In contrast to the long straight morphology of amyloid fibers (Fig. 4.2B), 
protofibers are short, worm-like aggregates of irregular shape with a lower amount of stable 
hydrogen bonded structure than mature amyloid fibers (36). Significantly, infrared spectroscopy 
suggests an antiparallel organization of the beta sheets rather than the parallel orientation found 
in amyloid fibers (37) with different contacts among the core than in amyloid fibers (35).  NMR 
studies have also suggested the β-strands are shorter in protofibers than amyloid fibers (38) and 
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that the side-chains of protofibers are more dynamic (35). The difference in structure translates 
to a difference in properties between the two species. Protofibers exist in a stable equilibrium 
with monomeric Aβ (20) and the transition between protofibers and monomeric Aβ is readily 
reversed by dilution (39). In contrast, the equilibrium concentration of monomer with amyloid 
fibers is very low (<1 µM) and the thermodynamic equilibrium strongly favors fiber formation 
(1,40). 
 For actual amyloid fibers, molecular details of the association steps involved in fiber 
elongation have been largely absent. Paramagnetic relaxation enhancement experiments using a 
fibril seed labeled at either A2 or A30 suggest that association of the monomer with the N-
terminus of the fiber during the docking stage is rare (41). Our experiments, which analyze the 
residue specificity of the monomer contacts in the docked state, offer a more detailed view of the 
docked state and highlight important differences between the docked state of the monomer in the 
fibers and protofibers. In protofibers, the KLVFFA sequence from residues 16-21 has the highest 
affinity for the protofiber surface (20,34). In actual fibers, the main recognition sequence of the 
docked state is shifted towards the C-terminus, centered on F19-E22 of the incoming monomeric 
peptide (Figs 4.2A and 4.5A). The shift is significant as the KLVFF sequence has been 
implicated in Aβ40 self-recognition and modified forms of the peptide sequence have been used 
for this reason as a motif in the design of peptide inhibitors targeting arresting fiber formation. 
This particular sequence was identified by finding the optimal binding sequence in a series of 
short peptides derived from the Aβ40 sequence (42). However, the KLVFF peptide is only 
moderately effective at suppressing both fiber formation and toxicity (43). A significant effect 
with short peptides is typically found only with a high excess of inhibitor. This finding is in 
contrast to the substantial effects seen at sub-stoichiometric levels with some longer peptides 
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(44) and antibodies (45) derived from the Aβ sequence; a difference which might be explained by 
a discrepancy between the optimal sequences for the locking and docking stages.  
4.4 Materials and Methods 
 Recombinant 15N-Aβ40 was purchased from rPeptide (Bogart, GA) and samples 
were prepared as described in ref 24. Unlabeled Aβ40 was purchased from Genscript USA, Inc. 
(Piscataway, NJ) and used to prepare fibril seeds under agitation at 37 ºC for 48 hours. All 
experiments were performed in 50 mM sodium chloride, 20 mM phosphate buffer, at pH 7.4. For 
Aβ40 samples prepared as fibril seeds, 0.01% NaN3 was added to phosphate buffer solutions. 
Aβ40 monomer samples were prepared to a concentration of ~76 µM, and verified by UV/Vis 
measurements with a Thermo Scientific Nanodrop 2000 (extinction coefficient 1490 M-1cm-1). 
NMR experiments were performed on a Bruker Avance 600 MHz spectrometer equipped with a 
5 mm cryogenic probe or on a Bruker Avance III 500 MHz NMR spectrometer equipped with a 
5 mm SMART probe. Real-time 2D NMR experiments were performed using the SOFAST-
HMQC technique and acquired consecutively for a minimum of 15 hours. Detailed methods are 
described in the Supporting Information.  
 
4.5 Contributions 
A.G., S.A.K., J.K., J.R.B., A.B., and A.R. performed NMR experiments and analyzed NMR 
results. B.R. expressed and purified uniformly 13C, 15N-labeled Aβ40. S.A.K., J.K., J.R.B., 
A.B., and A.R. designed the project and A.B. and A.R. directed the research.  
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Chapter 5: Conclusions and Future Outlook 
5.1 General Conclusions 
In this dissertation, we have explored the mechanism of Aβ aggregation in various 
environments and their influence on the potential pathway(s) aggregation may proceed. Prior 
studies demonstrated the role of membrane composition in modulation of Aβ aggregation, and 
hypothesized the specific role of gangliosides being a culprit of a toxic aggregation pathway (1, 
2). Nevertheless, the full role of how gangliosides may contribute mechanistically to this toxic 
aggregation remained unclear. More generally, many questions remained about how Aβ 
aggregation proceeds in solution at high resolution. Using a combination of biophysical 
approaches, namely NMR spectroscopy, we have provided new mechanistic insights into Aβ 
misfolding that are fundamental to understanding Alzheimer’s disease pathogenesis.  
Experimental results in Chapter 2 expand on previous investigations of Aβ aggregation in 
the presence of ganglioside-containing membranes by revealing their role in the membrane 
disruption process. We found that ganglioside-containing membranes facilitated a two-step 
mechanism of membrane disruption by which Aβ (i) formed ion-permeable pores and (ii) caused 
membrane fragmentation in a fiber-dependent and ganglioside-dependent manner. Pore 
formation had previously been observed for Aβ (3–5); however, our study demonstrated Aβ’s 
ability to cause membrane fragmentation and its dependence lipid composition, namely 
gangliosides. Additionally, this study accounts for many facets of Aβ toxicity through membrane 
disruption that were previously poorly explained. First, it sheds light on the mechanism by which 
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large aggregates of Aβ, which present difficulty in rationalizing their ability to form pores unless 
disassembled into smaller aggregates (energetically unfavorable), could elicit cytotoxicity. 
Second, Aβ aggregation is often accompanied by large-scale morphological changes in the 
membrane that would not be expected or observable by the insertion of small oligomeric pores. 
Rather, large-scale morphological changes point to physical disruption of membranes.  
While Chapter 2 demonstrated a potential mechanism by which Aβ may elicit 
neurotoxicity, the problem of aggregation remains the ultimate culprit of Aβ pathogenesis and 
the likely agent to target for development of AD therapeutics. More specifically, it highlights the 
knowledge lacking in structural morphologies of oligomeric intermediates; the “central dogma” 
of the amyloid problem (6). The inability to reconcile the morphological features of oligomeric 
Aβ assemblies lies in the shortcomings, thus far, of high-resolution tools for studying oligomeric 
structures as well as ongoing fibrillization. In Chapters 3 and 4, we explored promising advances 
in this regard by developing a method capable of obtaining high-resolution structural information 
of oligomers in situ and implementing new approaches in real-time 2D NMR for amyloid 
misfolding, respectively.  
Few structural models of Aβ oligomers exist (7–10), and this is largely due to their 
transient nature and heterogeneous structures, making oligomers of a specific conformation 
difficult to isolate and structural characterize. However, given that heterogeneity is so apparent 
in amyloid aggregation pathways, it seems that isolation of particular structures would only 
provide a narrow picture of the overall aggregation scheme. This becomes more evident when 
considering most of the models that do exist bear a close resemblance to the fiber end-product (7, 
11–13), while evidence from lower-resolution techniques (like CD) suggests some, but not all, of 
the most toxic oligomers have a structure that more closely resembles the Aβ monomer than the 
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Aβ fiber (14, 15). In Chapter 3, we use MAS NMR spectroscopy on a solution sample of Aβ 
containing a heterogeneous mixture of oligomers and fibers. Through slow MAS spinning speeds 
and the use of 1H-1H dipolar interactions, we spectrally filter any signal that might come from 
the insoluble fibers. By using the 1H/1H RFDR technique, we were able to reveal a dynamic and 
disordered structure comprised of turns and twists for intermediate sized (5-10 nm) oligomers 
without purification. In a more general sense, our results demonstrate the value of the RFDR-
based 2D 1H/1H experiment in obtaining high-resolution information on supramolecular 
assemblies not easily amenable to analysis by other biophysical techniques, including solution 
NMR and other solid-state NMR experiments.  
 The RFDR experiments offer new avenues to study oligomer structure, but in order to 
gain mechanistic insight into the process of their assembly will require advancements in pulses 
sequences with shorter acquisition times. Work in Chapter 4 demonstrates application of recently 
developed fast acquisition methods of 2D solution NMR pulse sequences towards a more 
detailed mechanistic understanding of Aβ fiber elongation. A proposed model for a “dock and 
lock” mechanism of fiber elongation had been proposed previously (16); however, site-specific 
details of the association steps involved in fiber elongation have been largely absent. 
Paramagnetic relaxation enhancement experiments using a fibril seed labeled at either A2 or A30 
suggest that association of the monomer with the N-terminus of the fiber during the docking 
stage is rare (17). Our experiments, which analyze the residue specificity of the monomer 
contacts in the docked state (the initial transient association of monomer to fiber), offer a more 
detailed view and highlight important differences between the docked state of the monomer in 
the fibers and protofibers. The central hydrophobic region of monomers (i.e. the sequence 
KLVFFA from residues 16-21) has the highest affinity for the protofiber surface (18). However, 
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in mature fibers, the main recognition sequence of the docked state is shifted towards the C-
terminus, centered on residues 19-22 (with sequence FFAE) of the incoming monomeric peptide 
(Figs 4.2 and 4.5). This shift is important, as the KLVFF sequence has been implicated as a site 
of Aβ40 self-recognition and may result from structural differences between protofibrillar and 
fibrillar states. Additionally, point mutations between residues F20-E22 give rise to early-onset 
Alzheimer’s disease and usually result in altered Aβ aggregation pathways and fibril structure 
(19–21). Real-time 2D NMR or similar experiments would need to be performed to provide 
molecular description of Aβ mutants associated with familial AD.  
Thus, the body of work presented in this dissertation implicates the role of Aβ in 
Alzheimer’s disease as a result of the overall of scheme of aggregation, as opposed to an 
individual toxic species. The heterogeneity of this assembly process emphasizes the difficulty in 
fully elucidating the specific nature of Aβ’s toxicity and further contributes to the uncertainty of 
pathogenic mechanisms of AD.  Nevertheless, the identification of site-specific interactions of 
Aβ self-assembly demonstrates the advantage of using NMR to establish the sequence of events 
in a protein aggregation reaction. Today, NMR is arguably the most powerful and well-suited 
method for doing so as it provides methods to identify the kinetics of aggregation, structures of 
different aggregate species, or structural transitions taking place during (mis)folding all at the 
atomic level. While solution- and solid-state NMR have distinct limitations, when combined they 
offer the ability to attack Aβ aggregation starting from monomeric (solution NMR) or fibrillar 
(solid-state NMR) species. Herein, the use of a combined solution/solid-state technique 
demonstrated the possibility for new avenues to probe such aggregation processes altogether; i.e. 
an approach to directly probe intermediate aggregation without perturbative methods, such as 
chemical- or photo-crosslinking, freezing, amino acid substitution, or any other type of protein 
 114 
engineering to stabilize the oligomers. With such insights, NMR is advancing to become an 
important tool for the study of Aβ aggregation as well as other aggregating proteins implicated in 
diseases like Parkinson’s or Huntington’s. Furthermore, as therapeutics for amyloid-related 
diseases are still inadequate, NMR shows the potential to unveil the interactions of aggregating 
proteins with drugs. 
5.2 Future Outlook 
NMR studies of Aβ, and other amyloidogenic proteins, offers continued progress in 
understanding the molecular basis of amyloid-related diseases. Currently, there are no 
therapeutics to prevent Alzheimer’s disease; however, progress in the area of drug development 
for amyloidoses, such as transthyretin amyloidosis (22, 23), provides confidence that anti-
amyloid drug targets are viable therapeutics for other amyloid-related diseases. The difficulty, 
however, with diseases such as Alzheimer’s and Parkinson’s diseases is likely due to the 
conformational plasticity of intrinsically disordered proteins as drug targets. NMR’s ability to 
probe the (mis)folding landscape would help identify such targets, and potentially establish the 
universality of the mechanisms of such processes uncovered herein.  
An intriguing result from our studies discussed in Chapter 2 of membrane-mediated 
modifications of Aβ aggregation is the ability of gangliosides to facilitate a specific aggregation 
pathway. Currently, the only membrane bound models of Aβ that exist are high-resolution 
structures of Aβ monomers bound to detergent micelles and computer simulations of channels or 
oligomers constructed from fragments of the Aβ fiber (24–26). The computer simulations of Aβ 
channels have been invaluable in identifying molecular features of potential Aβ pore structures, 
yet more structural data is necessary to further refine computational models and to collectively 
understand all forms of membrane disruption. It is apparent that membranes have a two-fold 
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effect on Aβ: (i) membranes can greatly accelerate the rate of fibrillization and (ii) Aβ can 
directly disrupt plasma and possibly organelle membranes. The cell membrane therefore 
contributes to Aβ toxicity as both a site for the accumulation/nucleation of toxic oligomers and 
as a target for their cytotoxic effect. Consequently, it is imperative to better understand how 
environmental factors within the cell membrane (such as the lipid composition) contribute to 
structural polymorphisms of Aβ oligomers. Such data will help us understand both how 
membrane disruption occurs and possibly if certain cell types are more sensitive to Aβ toxicity 
due to an altered lipid composition, generating a more toxic conformation. 
The potential of the 1H/1H RFDR approach presented in Chapter 3 offers new avenues for 
the study of human-derived samples of amyloid aggregates. A study from Tycko and co-workers 
reported structures of Aβ fibril structures derived from post-mortem brain tissue (27). While the 
work from Lu et al was a major breakthrough for AD reserach, high-resolution characterization 
of such samples still required seeded growth of synthetic 13C,15N-labeled Aβ40 peptide. The 
sensitivity of the 1H nucleus limits the need for large sample quantities typical of many NMR 
experiments. Furthermore, 1H-1H through-space correlations are routinely used for determining 
protein structure and dynamics (28–30). Here, we were unable to solve a distinct structure of an 
Aβ oligomer species due to its highly disordered nature limiting the number of measurable 
distant constraints. Our experiments did, however, reveal the ability to achieve atomic resolution 
and perhaps indicates that as a future structure-determination method may necessitate isotopic 
labelling of samples or development of pulse sequences with improved sensitivity.  
A deeper related question is how such Aβ aggregates self-associate to form 
heterogeneous intermediates, yet distinct polymorphs of amyloid fibrils. The real-time 2D NMR 
methods implemented for the study in Chapter 4 demonstrated to some degree the hierarchrical 
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nature of Aβ fiber elongation. Studies in our laboratory are presently ongoing to expand on the 
ability of the Aβ42 alloform to cross-seed aggregation, and vice versa. Yet, if there is 
dependence on a particular polymorphic structure to seed Aβ aggregation, then such studies can 
also be extended to observe how human brain-derived samples facilitate Aβ self-assembly. The 
study by Lu et al found that Aβ fibrils derived from different AD patients were structurally 
distinct (27). Given the inherent polymorphism of Aβ fibrils, this raises a number of intriguing 
questions about distinct pathways of Aβ assembly. Is the initial fibril formation stochastic, and 
then the same form predominantly replicated? Does a particularly polymorphic structure persist 
because of stronger seeding capabilities? Does particular polymorphic structure evade 
breakdown by protein quality control machinery and/or appropripate clearance? Do patients with 
different clinical histories give rise to similar mechanisms of self-assembly? 
Answers to such questions are likely only to be elucidated by further studies of larger 
patient populations. The NMR methods used here provide a valuable suite of tools to generate 
insight into the mechanism of Aβ self-assembly and the aggregation of amyloids, broadly. 
Beyond the above applications, the toxic nature of Aβ has yet to be established as causative in 
AD and this may be due to failure, thus far, in our inability to develop therapeutics capable of 
preventing Aβ aggregation in vivo. Our inability to do so could directly result from our lack of 
understanding of the intermediate states leading to fibril formation or aggregates that propagate 
unfavorable Aβ aggregation. In this respect, better understanding the link between environmental 
factors (such as lipid composition, metal ions, etc.) and their resultant effects on initial 
misfolding, nucleation of fibril formation, and/or propagation of fibril polymorphs are likely a 
key aspect to understanding Alzheimer’s disease and other amyloid-related diseases.  
 117 
5.3 References 
1.  Matsuzaki, K., Kato, K., and Yanagisawa, K. (2010) Abeta polymerization through 
interaction with membrane gangliosides. Biochim. Biophys. Acta. 1801, 868–77 
2.  Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2002) 
Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: 
importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer 
amyloid. Biochemistry. 41, 7385–7390 
3.  Arispe, N., Pollard, H. B., and Rojas, E. (1993) Giant multilevel cation channels formed 
by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc 
Natl Acad Sci U S A. 90, 10573–10577 
4.  Lal, R., Lin, H., and Quist, A. (2007) Amyloid beta ion channel: 3D structure and 
relevance to amyloid channel paradigm. Biochim. Biophys. Acta - Biomembr. 1768, 1966–
1975 
5.  Capone, R., Jang, H., Kotler, S. A., Kagan, B. L., Nussinov, R., and Lal, R. (2012) 
Probing structural features of Alzheimer’s amyloid-β pores in bilayers using site-specific 
amino acid substitutions. Biochemistry. 51, 776–85 
6.  Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic Aβ oligomer and 
Alzheimer’s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349–57 
7.  Chimon, S., Shaibat, M. A., Jones, C. R., Calero, D. C., Aizezi, B., and Ishii, Y. (2007) 
Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of 
Alzheimer’s β-amyloid. Nat. Struct. Mol. Biol. 14, 1157–64 
8.  Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van 
Nostrand, W. E., and Smith, S. O. (2010) Structural conversion of neurotoxic amyloid-
beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 17, 561–567 
9.  Scheidt, H. a, Morgado, I., Rothemund, S., Huster, D., and Fändrich, M. (2011) Solid-
state NMR spectroscopic investigation of Aβ protofibrils: implication of a β-sheet 
remodeling upon maturation into terminal amyloid fibrils. Angew. Chem. Int. Ed. Engl. 
50, 2837–40 
10.  Yu, L., Edalji, R., Harlan, J. E., Holzman, T. F., Lopez, A. P., Labkovsky, B., Hillen, H., 
Barghorn, S., Ebert, U., Richardson, P. L., Miesbauer, L., Solomon, L., Bartley, D., 
Walter, K., Johnson, R. W., Hajduk, P. J., and Olejniczak, E. T. (2009) Structural 
characterization of a soluble amyloid beta-peptide oligomer. Biochemistry. 48, 1870–7 
 118 
11.  Scheidt, H. a, Morgado, I., and Huster, D. (2012) Solid-state NMR reveals a close 
structural relationship between amyloid-β protofibrils and oligomers. J. Biol. Chem. 287, 
22822–6 
12.  Tay, W. M., Huang, D., Rosenberry, T. L., and Paravastu, A. K. (2013) The Alzheimer’s 
amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished 
structurally by intermolecular organization. J. Mol. Biol. 425, 2494–508 
13.  Lendel, C., Bjerring, M., Dubnovitsky, A., Kelly, R. T., Filippov, A., Antzutkin, O. N., 
Nielsen, N. C., and Härd, T. (2014) A Hexameric Peptide Barrel as Building Block of 
Amyloid-β Protofibrils. Angew. Chem. Int. Ed. Engl. 53, 12756–60 
14.  Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity relationships 
of amyloid beta-protein oligomers. Proc. Natl. Acad. Sci. U. S. A. 106, 14745–50 
15.  Ladiwala, A. R. a, Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., 
Van Nostrand, W. E., and Tessier, P. M. (2012) Conformational differences between two 
amyloid β oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 287, 24765–73 
16.  Esler, W. P., Stimson, E. R., Jennings, J. M., Vinters, H. V., Ghilardi, J. R., Lee, J. P., 
Mantyh, P. W., and Maggio, J. E. (2000) Alzheimer’s disease amyloid propagation by a 
template-dependent dock- lock mechanism. Biochemistry. 39, 6288–6295 
17.  Yamaguchi, T., Matsuzaki, K., and Hoshino, M. (2013) Interaction between soluble Aβ-
(1-40) monomer and Aβ-(1-42) fibrils probed by paramagnetic relaxation enhancement. 
FEBS Lett. 587, 620–624 
18.  Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A., and Clore, G. M. (2011) Atomic-
resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR. 
Nature. 480, 268–272 
19.  Tycko, R., Sciarretta, K. L., Orgel, J. P. R. O., and Meredith, S. C. (2009) Evidence for 
novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. Biochemistry. 48, 6072–
84 
20.  Lee, J., Culyba, E. K., Powers, E. T., and Kelly, J. W. (2011) Amyloid-beta forms fibrils 
by nucleated conformational conversion of oligomers. Nat Chem Biol. 7, 602–609 
21.  Yates, E. A., Cucco, E. M., Legleiter, J., Hall, C., Box, P. O., Virginia, W., and States, U. 
(2011) Point Mutations in Aβ Induce Polymorphic Aggregates at Liquid/Solid Interfaces 
22.  Razavi, H., Palaninathan, S. K., Powers, E. T., Wiseman, R. L., Purkey, H. E., 
Mohamedmohaideen, N. N., Deechongkit, S., Chiang, K. P., Dendle, M. T. A., 
Sacchettini, J. C., and Kelly, J. W. (2003) Benzoxazoles as transthyretin amyloid fibril 
inhibitors: synthesis, evaluation, and mechanism of action. Angew. Chem. Int. Ed. Engl. 
42, 2758–61 
 119 
23.  Coelho, T., Maia, L. F., Martins da Silva, A., Waddington Cruz, M., Plante-Bordeneuve, 
V., Lozeron, P., Suhr, O. B., Campistol, J. M., Conceicao, I. M., Schmidt, H. H.-J., Trigo, 
P., Kelly, J. W., Labaudiniere, R., Chan, J., Packman, J., Wilson, A., and Grogan, D. R. 
(2012) Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, 
controlled trial. Neurology. 79, 785–792 
24.  Jang, H., Connelly, L., Arce, F. T., Ramachandran, S., Lal, R., Kagan, B. L., and 
Nussinov, R. (2013) Alzheimer’s disease: which type of amyloid-preventing drug agents 
to employ? Phys. Chem. Chem. Phys. 10.1039/c3cp00017f 
25.  Jang, H., Zheng, J., Lal, R., and Nussinov, R. (2008) New structures help the modeling of 
toxic amyloidbeta ion channels. Trends Biochem. Sci. 33, 91–100 
26.  Jarvet, J., Danielsson, J., Damberg, P., Oleszczuk, M., and Gräslund, A. (2007) 
Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and 
paramagnetic probes. J. Biomol. NMR. 39, 63–72 
27.  Lu, J.-X., Qiang, W., Yau, W.-M., Schwieters, C. D., Meredith, S. C., and Tycko, R. 
(2013) Molecular structure of β-amyloid fibrils in Alzheimer’s disease brain tissue. Cell. 
154, 1257–68 
28.  Riek, R., Güntert, P., Döbeli, H., Wipf, B., and Wüthrich, K. (2001) NMR studies in 
aqueous solution fail to identify significant conformational differences between the 
monomeric forms of two Alzheimer peptides with widely different plaque-competence, 
Aβ(1-40) ox and Aβ(1-42) ox. Eur. J. Biochem. 268, 5930–5936 
29.  Riek, R., Hornemann, S., Wider, G., Glockshuber, R., and Wüthrich, K. (1997) NMR 
characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS 
Lett. 413, 282–8 
30.  Wälti, M. A., Orts, J., Vögeli, B., Campioni, S., and Riek, R. (2015) Solution NMR 
Studies of Recombinant Aβ(1-42): From the Presence of a Micellar Entity to Residual β-
Sheet Structure in the Soluble Species. Chembiochem. 10.1002/cbic.201402595  
 
 120 
Appendix A. Supporting Information for Chapter 2 
 
A.1. Additional Experimental Methods: 
A.1.1. Materials:  
Aβ40 (97% purity) was purchased from Anaspec (Fremont, CA). 1-palmitoyl-2- oleoyl-
sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
sodium salt (POPS), total ganglioside extract (Brain, Porcine-Ammonium Salt), and total brain 
lipid extract were purchased from Avanti Polar lipids Inc. (Alabaster, AL). Ferric chloride 
hexahydrate, ammonium  thiocyanate,  and  Fura-2  pentapotassium  salt  were  purchased  from 
Sigma-Aldrich (St. Louis, MO). 6-Carboxyfluorescein was purchased from Fluka. 
A.1.2. Model membrane preparation.  
Large unilamellar vesicles (LUV) of POPC/POPS 7/3, POPC/POPS/ganglioside 
5.5/3/1.5, and total lipid brain extract (TLBE) were prepared from a chloroform solution of 
lipids in the desired ratio. The solution was gently dried under nitrogen flow and then placed 
under a high vacuum overnight to further evaporate any residual solvent. The obtained lipid 
film was rehydrated with a buffer solution (10 mM phosphate buffer solution, pH 7.4, 100 mM 
NaCl), to yield a final concentration of 4 mg/ml, and dispersed by vigorous stirring. The 
resulting solution was extruded 23 times through a 100 nm polycarbonate Nucleopore 
membrane filter (Whatman) mounted on a mini-extruder in order to obtain LUV with an 
average diameter of 100 nm. 
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To prepare dye-filled LUV, the dry lipid film was hydrated with a buffer solution 
containing 6-carboxyfluorescein (10 mM phosphate buffer solution, 70 mM 6- 
carboxyfluorescein, 100 mM NaCl, pH 7.4) or 100 µM Fura 2 pentapotassium salt (10 
mM Hepes buffer solution, 200 µM EGTA, 100 mM NaCl, pH 7.4) to a final concentration of 
10 mg/ml, which was followed by the procedures described above. Removal of any non- 
encapsulated 6-carboxyfluorescein or Fura 2 pentapotassium salt was performed by running the 
extruded LUV solution through a Sephadex G50 gel exclusion column (Sigma-Aldrich) and 
collecting  the  first  colored  band  detectable  under  visible  or  UV  light  which  contained  
the separated  dye-containing  vesicles.  The  final  lipid  concentrations  were  measured  using  
the Stewart assay. All solutions were freshly prepared before each experiment. 
A.1.3. Dye  leakage  assay.  
 Membrane leakage experiments were carried out using 6- carboxyfluorescein-filled   
LUV composed of POPC/POPS 7/3, POPC/POPS/gangliosides 5.5/3/1.5 and total brain extract. 
Membrane leakage was detected by measuring the increase in fluorescence 6-
carboxyfluorescein resulting from its dilution and subsequent dequenching following membrane 
leakage. Samples were prepared by first diluting the dye-filled vesicles solution with buffer 
solution (10 mM phosphate buffer solution, 100 mM NaCl, pH 7.4) to a final concentration 
of 0.2 mg/ml. The presence of 100 mM NaCl in the buffer ensured that the osmotic pressure 
exerted on the membrane bilayer by the dye itself had no effect on dye release from the vesicles. 
The NaCl concentration was optimized by varying the NaCl concentration in the buffer outside 
the LUVs until baseline leakage in the absence of peptide was negligible over several days. To 
initiate membrane disruption, 1 or 2 µl of the peptide stock solution was added to 100 µl of the 
LUV solution to obtain a final peptide concentration of 5 or 10 µM , respectively. Experiments 
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were carried out in Corning 96 well non-binding surface plates. Time traces were recorded 
using Biotek Synergy 2 plate reader using a 2 nm bandpass filters at 494 nm excitation and 520 
nm emission at room temperature, shaking samples for 10 seconds before each read. The 
fraction of dye released was calculated by: 
Fraction of dye released = (I -I0)/(I100 - I0) 
where I is the emission intensity of the sample, I0  is the emission intensity 
obtained in theabsence of peptide (baseline control) and I100 is the emission intensity obtained 
after adding 1 µl of Triton X-100, a detergent which acted as a positive control to give 100% 
leakage. 
 
Figure A.1 Timescales of dye leakage and fiber formation.  
Comparison between t1/2, the time for the intensity to   reach   one   half   the   final   value,   for   0.2   
mg/ml   total   brain   extract   (TLBE), POPC/POPS/Ganglioside (5.5/3/1.5), and POPC/POPS (7/3) 
LUVs in the dye leakage and Thioflavin T assays. 
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Figure A.2 Membrane disruption induced by seeded fiber growth of Aβ40 measured by the 6- 
carboxyfluorescein dye leakage assay.  
Release of 6-carboxyfluorescein induced by the seeded growth of Aβ40 from 0.2 mg/ml total brain 
extract (TLBE) LUVs. Neither freshly dissolvedAβ40 (10 µM) or performed Aβ40 fibers (10 µM) 
caused dye release within the timescale of the experiment.  Addition of freshly dissolved Aβ40 to 
preformed fibers (indicated by the dashed line) caused immediate membrane disruption. Experiments 
were performed at room temperature in 10 mM phosphate buffer, 100 mM NaCl, pH 7.4; results are the 
average of three measurements. 
 
 
Figure A.3 Kinetics of calcium influx into LUVs after the addition of freshly dissolved Aβ40. 
Calcium ion influx detected by Fura 2 encapsulated in 0.2 mg/ml total lipid brain extract LUVs following 
the simultaneous addition of Ca+2 and 10 µM Aβ40. 
 124 
 
Figure A.4 Fura 2 is sensitive to membrane disruption by both Zn2+ and Ca2+.  
Influx of calcium (red line) and zinc (blue line) ions induced by 1 µM MSI-78 on 0.2 mg/ml total brain 
extract LUVs. Freshly dissolved MSI-78 was added to each sample at time zero, Ca2+ or Zn2+ was added 
at 600 seconds as indicated by the dashed line. 
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Appendix B. Supporting Information for Chapter 3 
 
B.1. Supplementary Figures 
 
 
Figure B.1 Characterizing the aggregated Aβ1-40 sample.  
The bis-ANS fluorescence assay was used to compare normalized bis-ANS fluorescence in solution 
(black) to its emission spectrum upon binding isolated Aβ1-40 fibrils (green).  
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Figure B.2 DLS studies on the spin-X-isolated oligomer and freshly dissolved samples of Aβ1-40.  
(a, b) The autocorrelation (a, blue circles) with a regularization fit and the corresponding distribution (b) 
of hydronamic radii obtained from the fitted autocorrelation of the spin-X isolated oligomer. DLS studies 
on the freshly dissolved Aβ1-40 sample (c, d) showing that the initial population of Aβ1-40 is primarily 
monomeric with some low order oligomers (dimers or trimers). This is apparent through a regularization 
fit of the autocorrelation (c) yielding a distribution of hydronamic radii (d) of the freshly dissolved Aβ1-40 
sample. 
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Figure B.3 The two-dimensional RFDR-based (top) and NOESY (bottom) 1H/1H chemical shift 
correlation experiments used in this study.  
 
 
Figure B.4 The aggregated Aβ1-40 sample shows strong up-field shifts.  
An overlay of the 1D 1H MAS NMR spectra of freshly dissolved Aβ1-40 (red) and the unfiltered, 
disordered Aβ1-40 oligomer (blue) acquired at 37 °C under 2.7 kHz MAS in 100% D2O, 10 mM sodium 
phosphate buffer, pH 7.4. 
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Figure B.5 1D 1H MAS spectra acquired under increasing MAS rates on the filtered disordered 
Aβ1-40 oligomer.  
Spectra were acquired at 600 MHz in 100% D2O, 10 mM phosphate buffer, pH 7.4 at 25 ºC. the filtered 
oligomer sample was lyophilized and re-hydrated to double its initial concentration, making for a total 
Aβ40 concentration of ~35 µM. 
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Figure B.6 An overlay of the aliphatic and alpha proton regions of RFDR-based 2D 1H/1H spectra 
acquired using mixing times of 20 ms (red) and 50 ms (black) on the aggregated Aβ1-40 sample.  
The spectra were acquired at 37 °C with an MAS rate of 2.7 kHz in 100% D2O, 10 mM phosphate buffer, 
pH 7.4. The slow MAS rate used here serves to insufficiently average the dipole-dipole interactions of the 
disordered oligomer such that the RFDR pulse sequence can be used to recouple its “residual” dipolar 
couplings under MAS conditions. The fact that a well-resolved RFDR-based 2D 1H/1H chemical shift 
correlation spectrum is obtained strongly suggests that this soluble, oligomer species is sufficiently large 
for the usage of such recoupling methods. Additionally, the low MAS rates insufficiently averages the 1H-
1H dipolar couplings of the fibrillar species present in the aggregated Aβ1-40 sample. Thus, the RFDR-
based 2D 1H/1H methodology effectively acts as a filter for intermediate aggregates of Aβ1-40. These 
spectra were assigned by using the 2D 1H/1H TOCSY spectrum of the filtered oligomer under both static 
and MAS conditions (see figures S4 and S7). Assignments of the two TOCSY spectra were guided by a 
previously assigned spectrum in the following study: Vivekanandan et al. BBRC, 2011, 411, 312-16. 
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Figure B.7 Time-course 1D 1H MAS NMR spectra of the aggregated Aβ1-40 sample, containing the 
disordered oligomer.  
Little difference is observed in the 1D 1H spectral profiles over the same timeframe for which the RFDR-
based 2D 1H/1H experiments were performed, indicating the disordered oligomer is stable over this time 
period. The initial time point of 4 days marks the completion of sample preparation period described in 
the experimental procedures and the starting point for all subsequent measurements performed on the 
disordered Aβ1-40 oligomer. While few changes are seen over this 16-day period, between 4 days and 9 
days there are several distinct changes occurring. The oligomer peaks ca. 0.15 ppm undergoes a drastic 
loss of signal between 4 and 9 days. Additionally, the doublet ca. 1.2 ppm is broadened beyond detection. 
Collectively, this would suggest 1) a heterogeneous mixture of Aβ1-40 oligomer species present at 4 days 
and 2) that the disordered oligomer(s) is growing in size over the course of 16 days.  
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Figure B.8 Two-dimensional 1H/1H NOESY experiments under 2.7 kHz MAS on the mixed fiber 
and oligomer sample of Aβ1-40.  
The spectrum was acquired with a 50 ms mixing time at 600 MHz in 100% D2O, 10 mM sodium 
phosphate buffer, pH 7.4, at 37 °C, and corresponds to the same sample used in Fig. 2 of the main text.   
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Appendix C. Supporting Information for Chapter 4 
 
C.1. Materials and Methods 
C.1.1. Preparation of Aβ samples:  
Unlabeled samples of Aβ1-40 were purchased from Genscript U.S.A., Inc (Piscataway, 
NJ). Uniformly 15N-labeled Aβ1-40 samples were purchased from rPeptide (Bogart, GA). To 
remove preformed aggregates, the purified peptide was dissolved in 1% ammonium hydroxide 
(v/v) at a concentration of 1 mg/ml followed by removal of the solvent by lyophilization for 24 
hours in aliquots of 0.1 mg. The aliqouted peptide was then stored at -20 ᴼC and only used once. 
Preparation of a primarily monomeric Aβ1-40 sample was performed as described 
previously (1). Briefly, 0.1 mg of the lyophilized peptide was first dissolved in 3 µl of DMSO 
and sonicated until the peptide was solubilized. The peptide solution was then hydrated in H2O 
(or 10% D2O for NMR measurements), buffered in 20 mM phosphate (pH 7.4), 50 mM NaCl 
and diluted to final peptide concentration of 76 µM (0.1 mg in 300 µl). The peptide concentration 
was confirmed by UV absorbance at 280 nm (ε280 = 1490 M-1 cm-1) 
For seeded NMR experiments, a fibrillar Aβ1-40 sample was prepared as described 
previously (2). The peptide was dissolved directly into a solution of 50 mM NaCl, 20 mM 
phosphate buffer with pH 7.4, 0.01% NaN3 and the peptide concentration was adjusted to 150 
µM (confirmed by UV absorbance). The sample was then kept at 37 °C with shaking for 48 hrs; 
conditions that produce a predominantly fibril sample of Aβ1-40.  
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C.1.2. Solution NMR spectroscopy:  
Solution NMR experiments were performed on a Bruker Avance 600 MHz spectrometer 
equipped with a 5 mm cryogenic probe or on a Bruker Avance III 500 MHz NMR spectrometer 
equipped with a 5 mm SMART probe. NMR experiments were performed at 10 °C, 25 °C, or 37 
°C. Prior to adding a fibril seed to the NMR tube containing monomeric Aβ1-40, a band-Selective 
Optimized-Flip-Angle Short-Transient HMQC spectrum was acquired to compare differences 
immediately before and after titration of fibrillar Aβ. Assignments of the monomer spectra were 
taken from previously assigned spectra found in the literature (3). 
To monitor Aβ1-40 aggregation with atomic resolution, real-time 2D NMR experiments 
were performed by consecutively acquiring 1H-15N SOFAST-HMQC spectra, with each 
spectrum collected over ~20 min. For seeded real-time HSQC experiments, Aβ1-40 fibril seeds 
were added to monomer solutions at concentrations of 5% and up to 30% of the total peptide 
concentration. At a 1:10 monomer to fiber ratio and 10 °C, real-time HSQC could be used to 
track the time-course depletion of monomer HSQC peaks in a site-specific manner. HSQC peak 
intensities of individual residues were plotted and fit to a single exponential equation. Real-time 
HSQC experiments were carried out and analyzed in similar fashion at both 25 °C and 37 °C. 
Diffusion coefficients were obtained from DOSY (diffusion ordered spectroscopy) NMR 
experiments (4) for the free Aβ1-40 monomer and in the presence of fibril seeds at different time 
points. All the experiments were performed using Bruker Avance 500 MHz NMR spectrometer 
equipped at 283 K. A series of one-dimensional 1H NMR spectra were recorded with 
incremented values of the gradient amplitude from 2% to 95% keeping 12 ppm spectral width, 
96 scans and 4 dummy scans. Before Fourier transformation, an exponential window function of 
2 Hz line broadening was applied followed by zeroth and first order phase as well as baseline 
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correction was done manually.  Diffusion coefficients were calculated from the following 
Stejskal–Tanner equation (5) 
I=Io  exp [-Dg2δ2γ2 ∇- δ3 ]................................................................(1) 
where I is the signal intensities at each gradient strength and Io is the signal intensity in 
the absence of  gradient pulse. D the diffusion coefficient, g is the gradient strength amplitude, δ 
is the duration of the gradient pulse, γ is the gyromagnetic ratio of 1H, and ∇ is the diffusion 
time. 
 
C.1.3. Transmission electron microscopy:  
Fibrillar samples of Aβ1-40 for transmission electron microscopy (TEM) analysis were 
deposited on continuous films on copper rhodium 100 mesh grids (Electron Microscopy 
Services, EMS, Hartfield, PA). Prior to adding samples, the grids were charged using a glow 
discharger for 15 s at 30 mA negative discharge. Fibrillar samples at a concentration of 150 µM 
were adsorbed to the grids for 2 minutes prior to rinsing with a 10 µL drop of freshly filtered 2% 
uranyl acetate (EMS) for 15 s before blotting excess stain. Samples were analyzed using a 
Philips CM-100 microscope operating at 80 kV. 
 135 
 
Figure C.1 Chemical shift perturbations of Aβ1-40 over time following titration of Aβ1-40 fibers.  
The chemical shift perturbation was taken as the difference between the time point before and after fiber 
addition using the following equation: Δδ =    (Δ𝛿𝛮  ×0.2)! + (Δ𝛿𝐻)! 
Solid lines are the average chemical shift perturbations and dotted lines are the average plus/minus one 
standard deviation.   
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Figure C.2 Time-course intensity changes of HSQC peaks of a seeded Ab40 sample at 10 ºC.  
All data are fit to a single exponential function. The seed concentration is 7% of the total Aβ1-40  
concentration. 
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Figure C.3 Time-course intensity changes of HSQC peaks of a seeded Aβ1-40 sample at 25 ºC.  
All data are to a single exponential function. The seed concentration is 7% of the total Aβ40 
concentration. 
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Figure C.4 One-dimensional 1H slices taken from the glycine region of the real-time HSQC 
measurements.  
The corresponding decay and build-up these HSQC peaks strongly suggests that the new peaks come 
from residues G33 and G37. 
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Figure C.5 Real-time HSQC experiments over an extended time period show that the most of the 
Aβ1-40 monomer is pushed towards a fibril-bound state.  
This is evidenced by the fact that almost all HSQC peaks end are distinct from that of the monomer at 0 
hrs. The concentration of fiber seed was increased up to 30% of the total Aβ40 concentration. All 
experiments were acquired at 10 ºC.  
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Figure C.6 Assigned 1H-15N HSQC spectrum of the seeded Aβ1-40 sample at a late stage of the 
aggregation process.  
3D HNCA and HN(CA)CB spectra were acquired on a 800 MHz spectrometer at 10 ºC. A partial 
assignment was possible of the new peaks arising from the slow exchange of fibril with monomer.  New 
peaks are indicacted with a prime or double prime. 
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Figure C.7 Time-course Diffusion Order SpectroscopY (DOSY) experiments performed on Aβ1-40 in 
the presence of a 10% fiber seed.   
The insignificant change in diffusion coefficient over the course of 15 hrs demonstrates that no new 
oligomer species forms in the presence the fiber seed, pointing to monomeric Aβ1-40 interacting with the 
fibers directly.  
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Figure C.8 Sonication accelerates the formation of new peaks arising from the slow exchange 
between free and fiber-bound forms of monomeric Aβ1-40.  
In samples that were not subjected to sonication following addition of a 10% fiber seed (Left panel), new 
peaks typically took 3-5 hours to appear in 1H-15N HSQC spectra (blue spectrum). Conversely, in samples 
that were subjected to sonication, new peaks appeared after 45 min (green spectrum, right). Sonication 
serves to break up fibers and increase the total surface area of accessible fiber ends, suggesting that new 
peaks arise from monomeric Aβ1-40 binding at the exposed fiber ends. In both panels, spectra before 
addition of fiber seeds are represented as single black contour lines.   
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Figure C.9 Time-course 1D 1H spectra of seeded Aβ1-40 aggregation.  
Increasing spectral dispersion of the amide region in the 1D 1H spectra points the visible Aβ1-40 species 
taking on secondary structure. Additionally, the line broadening suggests the Aβ1-40 monomer is in 
chemical exchange with the fibrillar Aβ1-40 species.  
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